Introduction {#s1}
============

Cell-cell communication in the nervous system occurs at specialized structures called synapses, where nerve signals propagate from a presynaptic neuron to a postsynaptic target cell. The postsynaptic apparatus containing a high density of neurotransmitter receptors represents an important feature of chemical synapses. In the past decades, tremendous effort has been made in understanding how the synthesis, trafficking, localization, and clustering of neurotransmitter receptors at the postsynaptic sites regulate synaptic formation, function, and plasticity in both central and peripheral synapses ([@bib24]; [@bib34]; [@bib37]; [@bib45]). Many of those studies were performed using the neuromuscular junction (NMJ), a simple peripheral chemical synapse. At the postsynaptic apparatus of NMJs, acetylcholine receptor (AChR) molecules are clustered at a nearly crystalline density of \~10,000 receptors/μm^2^ ([@bib14]); in contrast, its density drops drastically to \<10 receptors/μm^2^ at the extra-synaptic regions. However, the detailed molecular mechanisms underlying the formation and maintenance of densely clustered AChR molecules at the postsynaptic apparatus are not fully understood.

Previous knockout studies showed that even in the absence of motor neurons, AChR clusters can still be found in muscle fibers in vivo ([@bib25]; [@bib47]), suggesting that such AChR pre-patterns are spontaneously formed via muscle-intrinsic mechanisms. Interestingly, a similar structure of aneural AChR clusters can be induced in *Xenopus* primary muscles or immortalized C2C12 myotubes by culturing them on substratum coated with laminin, a major structural glycoprotein in the extracellular matrix (ECM) ([@bib21]; [@bib23]). These aneural AChR clusters, located at the bottom surface of cultured muscles in direct contact with ECM proteins, may undergo topological transformation, which is mirrored by the progressive structural changes in synaptic AChR clusters during NMJ maturation in vivo ([@bib21]). Our previous work showed that actin-rich structures are highly concentrated at the perforated regions of aneural AChR clusters ([@bib23]). These structures were later shown to share the typical characteristics of podosome-like structures (PLSs) ([@bib32]). PLSs, initially identified as dynamic foot-like structures in motile or invasive cells, have been linked to pathophysiological processes such as cancer cell invasion and metastasis via local proteolysis of ECM proteins ([@bib26]). It is worth to note that a small proportion of aneural AChR clusters can also be identified at the top surface of cultured muscles, and these spontaneously formed clusters are likely mediated through ECM- and PLS-independent mechanisms. At the NMJ, the exact functions of synaptic PLSs in regulating AChR cluster formation and remodeling remain largely unclear. In this study, we show that the assembly of PLSs, which can be induced by different ECM proteins, focally regulates matrix degradation for AChR clustering and topological remodeling. Next, we further demonstrate that intracellular trafficking and surface insertion of membrane-type 1 (MT1-) matrix metalloproteinase (MMP) are mediated via microtubule-capturing mechanisms at PLSs, which in turn spatiotemporally regulate the topological remodeling of aneural AChR clusters and their dispersal upon synaptic induction. Inhibition of MMP activity or reduced expression of muscle MT1-MMP greatly suppresses nerve-induced AChR cluster formation and stabilizes aneural AChR clusters against dispersal. Lastly, we show that MT1-MMP is required for the recruitment of AChR molecules from aneural to synaptic AChR clusters at developing NMJs in vitro and in vivo. Taken together, this study revealed the significance of PLS-directed MT1-MMP trafficking and surface insertion in modulating the assembly and topological remodeling of AChR clusters via focal matrix degradation at developing neuromuscular synapses.

Results {#s2}
=======

Topologically complex structures of PLS-associated aneural AChR clusters can be induced by different ECM proteins {#s2-1}
-----------------------------------------------------------------------------------------------------------------

When dissociated myotomal tissues from early *Xenopus* embryos were cultured on glass coverslips coated with a mixture of ECM proteins, containing entactin/nidogen, collagen and laminin (ECL), topologically complex aneural AChR clusters were observed mostly on the bottom surface of muscle cells in contact with ECL-coated substratum ([Figure 1A](#fig1){ref-type="fig"}). Some aneural AChR clusters could also be found within the top surface of muscle cells but exhibited a sparsely scattered morphology. To further identify if specific ECM proteins are required for the formation of these topologically complex AChR clusters, we tested several key ECM proteins individually, including laminin, collagen, and gelatin, for their ability to induce AChR cluster formation in cultured *Xenopus* muscle cells. We found that the formation of bottom AChR clusters could be effectively induced by all ECM proteins tested, in contrast to the negative control using poly-D-lysine (PDL), a polypeptide commonly used to promote cell attachment ([Figure 1B](#fig1){ref-type="fig"}). In immortalized C2C12 myotubes, aneural AChR clusters can undergo a topological transformation from a plaque to a perforated pretzel-shaped, and eventually to C-shaped arrays ([@bib21]). Hence, we further classified the aneural AChR clusters in *Xenopus* muscle cultures into scattered, plaque, perforated, and C-shaped based on their morphological features. A majority of ECM-induced aneural AChR clusters exhibited perforated structures. While the percentage of muscle cells with AChR clusters was largely reduced on PDL-coated substrate, the largest share of AChR clusters exhibited scattered structures (9.59% out of 13.33% total) ([Figure 1C](#fig1){ref-type="fig"}), similar to those structures found on the top muscle surface. As opposed to a previous study showing the topological transformation of AChR clusters in C2C12 myotubes ([@bib21]), most AChR clusters, regardless of their topological features, were gradually dispersed over 6 days in cultured *Xenopus* muscle cells ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Our previous study indicated that actin depolymerizing factor (ADF)/cofilin, one of the molecular components in PLSs, regulates the formation and maintenance of AChR clusters via vesicular trafficking ([@bib23]). Here, we further performed immunostaining of several typical core markers (composed of F-actin and actin-associated proteins, such as ADF/cofilin, Arp2/3 complex, and cortactin) and cortex markers (composed of adhesion molecules, such as vinculin, talin, and paxillin) of PLSs. All these markers were found to be enriched in the perforations (arrows) of AChR clusters in *Xenopus* muscle cultures ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). As cortactin is highly enriched and involved in both early and late stages of PLS formation ([@bib44]), we then used cortactin as an indicator of PLS localization in AChR clusters. PLSs were spatially concentrated in a majority of perforated AChR clusters induced by different ECM proteins ([Figure 1D and E](#fig1){ref-type="fig"}). In contrast, PLSs were not localized in AChR clusters, even in a small fraction of AChR clusters (2.16% out of 13.33% total) exhibiting perforated structures, on PDL substrates. These data suggest that different ECM proteins can induce the assembly of PLSs, which may in turn promote the formation of topologically complex structures of AChR clusters.

MMP-mediated ECM degradation regulates topological remodeling of aneural AChR clusters {#s2-2}
--------------------------------------------------------------------------------------

The data above showed that perforated AChR clusters can be effectively induced by gelatin ([Figure 1B and C](#fig1){ref-type="fig"}), an ECM protein that was previously shown to induce simple AChR plaques only ([@bib21]). This novel finding prompted us to adopt the well-established fluorescent gelatin degradation assay ([@bib38]) to investigate the possible association between matrix degradation and PLS localization in AChR clusters. After plating the muscle cells on FITC-gelatin-coated substratum, confocal microscopy was performed to visualize the extent of gelatin degradation in 3 day old live *Xenopus* primary muscle cells. We observed FITC-gelatin that was extensively degraded in close association with the perforated regions of aneural AChR clusters ([Figure 2A](#fig2){ref-type="fig"}). Next, we quantitatively measured the fluorescence intensity of FITC-gelatin in different AChR clusters and identified a linear relationship between the extent of gelatin degradation and the perforation area of aneural AChR clusters ([Figure 2B](#fig2){ref-type="fig"}). A similar spatially restricted gelatin degradation pattern was observed in cultured C2C12 myotubes ([Figure 2C](#fig2){ref-type="fig"}). Besides gelatin, immunostaining experiments also showed the spatial degradation of laminin at the perforated regions of AChR clusters in *Xenopus* primary muscle cells ([Figure 2D](#fig2){ref-type="fig"}).

![Topologically complex structures of PLS-associated aneural AChR clusters can be induced by different ECM proteins.\
(**A**) A schematic diagram illustrating the location and morphological features of aneural AChR clusters found in the top versus bottom surface of cultured *Xenopus* muscle cells. Maximal projection of confocal z-stack images was constructed from 11 frames with 3 µm z-interval. (**B**) Quantification on the presence of top versus bottom aneural AChR clusters in muscle cells cultured on substratum coated with different ECM proteins or PDL. n = 300 cells in each condition from 3 independent experiments. (**C**) Representative images showing several distinct morphological features of aneural AChR clusters (scattered, plaque, perforated, and C-shaped), and the quantification showing the population of aneural AChR clusters with respective morphological features in muscle cells cultured on different ECM substrates or PDL. n = 150 cells in each condition from 3 independent experiments. (**D**) Representative images showing cortactin immunostaining of 2-d old *Xenopus* muscle cells to indicate the presence of PLSs at the perforated regions of aneural AChR clusters. (**E**) Quantification on the percentage of aneural AChR clusters associated with cortactin enrichment in muscle cells cultured on substratum coated with different ECM proteins or PDL. n = 150 cells in each condition from 3 independent experiments. Scale bars represent 10 μm. Data are represented as mean ± SEM. One-way ANOVA with Dunnett's multiple comparisons test, \*, \*\*, \*\*\* represent p≤0.05, 0.01, and 0.001 respectively.](elife-54379-fig1){#fig1}

![MMP-mediated ECM degradation regulates topological remodeling of aneural AChR clusters.\
(**A**) Representative confocal z-stack images showing the discrete and extensive degradation of fluorescent gelatin at the perforated regions within aneural AChR clusters. (**B**) Scatter plot analysis showing a positive correlation between the fluorescent gelatin intensity in perforated AChR clusters (a) divided by that in another region of the same cell (b) and the area of AChR-rich region (a) divided by that of the entire AChR clusters with perforations (a+p). R = 0.6458, p\<0.0001. n = 84 from 3 independent experiments. (**C--D**) Representative images showing the degradation patterns of fluorescent gelatin (**C**) and laminin immunostaining (**D**) at AChR clusters in cultured C2C12 myotubes and *Xenopus* primary muscle cells, respectively. (**E**) Representative images showing the inhibitory effects of BB-94 or BB-2516 on fluorescent gelatin degradation. Dotted lines indicate the periphery of muscle cells. (**F**) Quantification on the extent of fluorescent gelatin degradation at the perforated regions of AChR clusters in control and BB-94/BB-2516-treated muscle cells over the first 4 consecutive days in culture. n \> 280 muscle cells in each condition from 3 independent experiments. (**G**) Quantification on the effects of BB-94 or BB-2516 on the formation of bottom AChR clusters in cultured *Xenopus* muscle cells. n = 150 muscle cells in each condition from 3 independent experiments. (**H**) Quantification on the effects of BB-94 or BB-2516 on the stability of bottom AChR clusters in cultured *Xenopus* muscle cells. n = 166 (Control), 154 (BB-94), and 137 (BB-2516) muscle cells from 3 independent experiments. (**I**) Representative sets of time-lapse images showing the topological changes and fluorescence intensity of AChR clusters in control (left panels) and BB-94-treated (right panels) muscle cells. 8-bit pseudo-color images highlight the difference in AChR intensity at the same aneural clusters over 96 hr with or without BB-94 treatment. (**J**) An individual value plot showing the percentage change in the area of each aneural AChR clusters at different time-points between control and BB-94-treated cells. n = 43 (Control) and 38 (BB-94) muscle cells from 3 independent experiments. Data are represented as mean ± SD. Scale bars represent 5 μm. Data are represented as mean ± SEM, unless otherwise specified. Two-way ANOVA with Dunnett's multiple comparisons test (**F**), one-way ANOVA with Dunnett's multiple comparisons test (**G and H**), two-way ANOVA with Sidak's multiple comparisons test (**J**), \*, \*\*\*, \*\*\*\* represent p≤0.05, 0.001, and 0.0001 respectively.](elife-54379-fig2){#fig2}

To examine if the focal degradation pattern of ECM proteins is mediated by MMP activity, we first used two broad-spectrum MMP inhibitors, BB-94 and Marimastat (BB-2516), which are known to be highly potent against MMP-1, -2, -3, -7, -9 and MT1-MMP ([@bib4]). Although perforated AChR clusters could be identified in muscle cells treated with 5 µM BB-94 or 10 µM BB-2516, the degradation of fluorescent gelatin associated with these perforated AChR clusters was completely abolished ([Figure 2E and F](#fig2){ref-type="fig"}). Quantification further demonstrated that the initial formation of aneural AChR clusters in muscle cells was largely unaffected in the presence of MMP inhibitors ([Figure 2G](#fig2){ref-type="fig"}). To investigate if PLS-associated MMP activity regulates the topological remodeling of AChR clusters, we monitored the same group of muscle cells over 2 days after aneural AChR clusters had been formed. We observed a significant reduction in the number of aneural AChR clusters in control muscle cells, in contrast to BB-94 or BB-2516 treatment that caused a slight increase in the number of aneural AChR clusters ([Figure 2H](#fig2){ref-type="fig"}). To further explore if MMP activity regulates the topological remodeling of AChR clusters, we performed time-lapse imaging to monitor the dynamic changes in AChR cluster morphology and intensity in response to BB-94 treatment. AChR clusters were first labeled with fluorescent α-bungarotoxin (0 hr), then they were monitored for 96 hr after treatment. In control untreated cells, we observed a gradual dispersal of aneural AChR clusters over the 96 hr imaging period; however, such spontaneous dispersal and topological remodeling of AChR clusters were largely inhibited by BB-94 treatment within the same imaging period ([Figure 2I and J](#fig2){ref-type="fig"}). These data demonstrated that MMP activity is involved in the topological remodeling and dispersal of aneural AChR clusters.

MT1-MMP activity precisely controls the extent of ECM degradation and AChR cluster formation {#s2-3}
--------------------------------------------------------------------------------------------

The spatially restricted patterns of gelatin degradation suggested the possible involvement of membrane-type MMPs (MT-MMPs) in modulating ECM environment focally to regulate AChR cluster remodeling and dispersal. To test this, we first performed immunostaining of *Xenopus* muscle cells and detected endogenous MT1-MMP that was enriched in the perforations of aneural AChR clusters ([Figure 3A](#fig3){ref-type="fig"}). Next, we over-expressed MT1-MMP-mCherry construct in muscle cells via *Xenopus* embryo microinjection. In MT1-MMP-mCherry-overexpressing muscle cells, we observed extensive degradation of fluorescent gelatin in the entire cell area ([Figure 3B](#fig3){ref-type="fig"}), in contrast to the spatially restricted degradation pattern at the perforated regions of AChR clusters in control cells. In addition, MT1-MMP-mCherry overexpressing cells showed a lower percentage of ECM-induced bottom AChR clusters, but a higher percentage of top AChR clusters, in comparison to the wild-type control cells ([Figure 3C](#fig3){ref-type="fig"}). Quantitative analyses on those bottom AChR clusters in MT1-MMP-mCherry-overexpressing cells showed that the intensity of aneural AChR clusters was significantly reduced, which was accompanied by the extensive gelatin degradation ([Figure 3D](#fig3){ref-type="fig"}). Interestingly, BB-94 or BB-2516 treatment was able to partially revert the distribution of aneural AChR clusters from the top surface back to the bottom surface of MT1-MMP-mCherry-overexpressing muscle cells ([Figure 3C](#fig3){ref-type="fig"}). Consistent with that, the extensive degradation of fluorescent gelatin and the reduction of AChR intensity caused by MT1-MMP-mCherry overexpression were largely rescued by either BB-94 or BB-2516 treatment ([Figure 3D](#fig3){ref-type="fig"}). Our results indicated that the precise control of focal ECM degradation by MT1-MMP at the perforated sites plays an essential role in the formation of bottom aneural AChR clusters.

![MT1-MMP activity precisely controls the extent of ECM degradation and AChR cluster formation.\
(**A**) Representative images showing the spatial localization of endogenous MT1-MMP in perforations of aneural AChR clusters (arrows) in fixed *Xenopus* muscle cultures. (**B**) Representative images showing the extent of fluorescent gelatin degradation in area covered by MT1-MMP-mCherry-overexpressing (MT1-mCherry) muscle cells in the presence or absence of MMP inhibitors BB-94 or BB-2516. 8-bit pseudo-color images highlight the relative fluorescence intensity of AChR clusters in different conditions. (**C**) Quantification on the effects of MT1-MMP-mCherry overexpression on the formation of AChR top and bottom clusters in response to BB-94 or BB-2516 treatment. n = 163 (Control), 123 (MT1-mCherry), 119 (MT1-mCherry + BB-94), and 62 (MT1-mCherry + BB-2516) muscle cells from 4 independent experiments. (**D**) Quantification on the effects of MT1-MMP-mCherry overexpression on the extent of fluorescent gelatin degradation and the intensity of aneural AChR clusters in response to BB-94 or BB-2516 treatment. For gelatin intensity measurement: n = 30 (Control), 39 (MT1-mCherry), 33 (MT1-mCherry + BB-94), and 31 (MT1-mCherry + BB-2516) muscle cells from 3 independent experiments. For AChR intensity measurement: n = 14 (Control), 19 (MT1-mCherry), 21 (MT1-mCherry + BB-94), and 16 (MT1-mCherry + BB-2516) muscle cells from 3 independent experiments. Scale bars represent 10 μm. Data are represented as mean ± SEM. One-way ANOVA with Dunnett's multiple comparisons test (**C**), one-way ANOVA with Turkey's multiple comparisons test (**D**), \*, \*\*, \*\*\*\* represent p≤0.05, 0.01, and 0.0001 respectively.](elife-54379-fig3){#fig3}

Cortical microtubule capturing is mediated by EB1-/CLASP-dependent mechanisms at perforated AChR clusters {#s2-4}
---------------------------------------------------------------------------------------------------------

To investigate the cytoskeletal involvement for intracellular trafficking of MT1-MMP, we next performed total internal reflection fluorescence (TIRF) microscopy to visualize the perimembrane fraction of GFP-tagged microtubule plus end-binding protein 1 (EB1-GFP) in live cultured muscle cells. Interestingly, we observed EB1-GFP comets to be highly enriched at the perforated aneural AChR clusters ([Figure 4A](#fig4){ref-type="fig"}). This pattern of EB1-GFP comets was not an artifact of overexpression, as a similar localization pattern of endogenous EB1 signals was also detected in fixed *Xenopus* muscle cells ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). By analyzing the density and trajectory of EB1-GFP comets in time-lapse images, we found that EB1-GFP comets were densely localized, but they showed lower mobility, at sites of aneural AChR clusters than other regions of the cell ([Figure 4B and C](#fig4){ref-type="fig"}). These data suggested that AChR clusters are the focal point of directed microtubule-based intracellular transport. Previous studies showed that cytoplasmic linker-associated protein (CLASP) and LL5β, a PLS cortex protein involved in NMJ development ([@bib20]), interact with microtubules to direct the vesicular trafficking of different proteins to the NMJ ([@bib3]). Thus, we examined if CLASP is required for directing the movement of EB1-GFP comets to PLS-enriched AChR clusters using antisense morpholino oligonucleotide (MO)-mediated knockdown approach. As validated by western blot analysis, endogenous CLASP protein level was largely reduced in *Xenopus* embryos microinjected with CLASP-MO ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). In CLASP-MO muscle cells, TIRF microscopy showed the perimembrane signals of EB1-GFP that were primarily found at the center of perforations within aneural AChR clusters ([Figure 4A](#fig4){ref-type="fig"}). Although the density of EB1-GFP comets was only slightly reduced at AChR cluster region ([Figure 4B](#fig4){ref-type="fig"}), the average speed of EB1-GFP comets in the region of AChR clusters was significantly increased by 26.7% to 0.12 ± 0.004 μm/s in CLASP-MO muscle cells ([Figure 4C](#fig4){ref-type="fig"}), indicating that CLASP is involved in microtubule capturing at aneural AChR clusters.

![Cortical microtubule capturing is mediated by EB1-/CLASP-dependent mechanisms at perforated AChR clusters.\
(**A**) Representative TIRF images showing the density and speed of EB1-GFP comets in AChR cluster versus and non-AChR regions between control and CLASP-MO muscle cells. The trajectories of EB1-GFP comets (purple dots) were constructed from 7 frames in 18 s, and then color-coded to reflect their speed. Yellow dotted lines indicate the location of AChR clusters. (**B--C**) Quantitative analyses showing the density (**B**) and speed (**C**) of EB1-GFP comets in AChR cluster and non-AChR regions between control and CLASP-MO muscle cells. n = 16 (Control), and 13 (CLASP-MO) cells from 3 independent experiments. (**D**) Representative TIRF images showing the differential perimembrane localization of EB1-GFP signals at aneural AChR clusters in control and CLASP-MO muscle cells. Arrows and arrowheads indicate the spatial enrichment of EB1-GFP signals at AChR clusters. (**E**) Line profiles showing the relative fluorescence intensities of AChR (red) and EB1-GFP (green) signals along the dotted lines indicated in merge image in panel D. The perforated region was defined by a cutoff intensity (55%) of the maximum, and the EB1 peaks were marked based on the line profiles. (**F**) Representative sets of time-lapse images showing the fluorescence recovery of EB1-GFP signals after photobleaching the region of aneural AChR clusters (dotted rectangle) in control and CLASP-MO muscle cells. Arrows and arrowheads indicate the spatial recovery of EB1-GFP signals in control and CLASP-MO muscle cells, respectively. (**G--H**) Quantification showing the FRAP curves (**G**) and the calculated recovery half time (**H**) of EB1-GFP signals in control versus CLASP-MO muscle cells. n = 18 (Control) and 14 (CLASP-MO) cells from 4 independent experiments. Scale bars represent 10 μm. Data are represented as mean ± SEM. Student's t-test, \*, \*\*, \*\*\* represent p≤0.05, 0.01, and 0.001 respectively. n.s.: non-significant.](elife-54379-fig4){#fig4}

To further study the directed trafficking and local capturing of EB1-GFP at aneural AChR clusters, we performed TIRF in combination with fluorescence recovery after photobleaching (FRAP) experiments. Before photobleaching, EB1-GFP signals were primarily enriched at the edge of perforations of aneural AChR clusters in control cells but at the center of perforations in CLASP-MO muscle cells ([Figure 4D](#fig4){ref-type="fig"}). To better show the spatial patterns of EB1-GFP signals at the perforations of aneural AChR clusters in control versus CLASP-MO muscle cells, we have plotted the fluorescence intensity profiles of EB1-GFP and AChR across a perforated region of AChR clusters, as indicated in [Figure 4D](#fig4){ref-type="fig"}. In the control cell, the peaks of EB1-GFP intensity showed a slight lateral shift towards the center of a perforated region (Top chart, [Figure 4E](#fig4){ref-type="fig"}), indicating the preferential enrichment of EB1-GFP at the edge of perforations. In contrast, CLASP knockdown caused the peak of EB1-GFP intensity to cover a larger area of a perforated region, indicating that EB1-GFP is enriched relatively closer to the center of perforations (Bottom chart, [Figure 4E](#fig4){ref-type="fig"}). After photobleaching the region of perforated AChR clusters (dotted rectangles in [Figure 4F](#fig4){ref-type="fig"}), we performed time-lapse imaging that reflects the rapid recovery of EB1-GFP fluorescence signals (in seconds after photobleaching). Spatially, the recovery of EB1-GFP signals was detected near the edge of those perforations within AChR clusters in control cells (arrows in [Figure 4F](#fig4){ref-type="fig"}, [Figure 4---video 1](#fig4video1){ref-type="video"}), but it was largely reduced in CLASP-MO muscle cells (arrowheads in [Figure 4F](#fig4){ref-type="fig"}, [Figure 4---video 2](#fig4video2){ref-type="video"}), leading to a significant increase in the half-time of EB1-GFP signal recovery by 58% from 5.71 ± 0.83 s in control cells to 9.01 ± 0.71 s in CLASP-MO muscle cells ([Figure 4G and H](#fig4){ref-type="fig"}). Collectively, our data suggested that PLSs may direct the vesicular trafficking to AChR clusters through EB1-/CLASP-mediated microtubule-capturing mechanisms.

Intracellular trafficking of MT1-MMP is directed to PLS-associated AChR clusters {#s2-5}
--------------------------------------------------------------------------------

As microtubules serve as major tracks for vesicular trafficking in mammalian cells, the cortical microtubule organization plays a crucial role in the targeted delivery of secretory and membrane proteins via exocytosis ([@bib28]). To further investigate if MT1-MMP intracellular trafficking is mediated by microtubule-based transport, we performed dual-channel live-cell imaging on *Xenopus* muscle cells over-expressing both MT1-MMP-mCherry and EB1-GFP ([Figure 5A](#fig5){ref-type="fig"}). In region 'i', some MT1-MMP-mCherry vesicles (arrows) were found to be initially immobile at the beginning of this time-lapse series, until they were captured by a moving EB1-GFP comet (arrowhead), leading to a coordinated movement of both EB1-GFP and MT1-MMP-mCherry signals from 27 s to 29 s time-points in this imaging period (middle row, [Figure 5A](#fig5){ref-type="fig"}). Another example in region 'ii' indicated that MT1-MMP-mCherry vesicles (arrows) were able to move bidirectionally on microtubule structures, as visualized by the fading tracks (arrowheads) generated by moving EB1-GFP comets (bottom row, [Figure 5A](#fig5){ref-type="fig"}). The spatiotemporal correlation between MT1-MMP-mCherry and EB1-GFP signals was better appreciated by constructing kymographs using multiple timeframes along 'K1' and 'K2' lines ([Figure 5B](#fig5){ref-type="fig"}). In these two kymographs, most MT1-MMP-mCherry vesicles were found to be relatively immobile. Interestingly, we observed some displacement of MT1-MMP-mCherry vesicles immediately after EB1-GFP comets had come into contact with them (arrows in [Figure 5B](#fig5){ref-type="fig"}). Consistent with the subcellular localization of MT1-MMP-mCherry, immunostaining data revealed that endogenous MT1-MMP exhibited punctuated structures inside the muscle cells, and some of them were co-localized with vesicle-associated membrane protein 1 (VAMP1) ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Taken together, these data illustrated that EB1 coordinates the vesicular trafficking of MT1-MMP in cultured muscle cells.

![Intracellular trafficking of MT1-MMP is directed to PLS-associated AChR clusters.\
(**A**) Representative images showing the intracellular trafficking of MT1-MMP vesicles in a cultured muscle cell expressing both MT1-MMP-mCherry (MT1-mCherry) and EB1-GFP. The time-lapse series of two regions (i and ii) outlined in the merge image showed (i) the search-and-capture of MT1-mCherry vesicles (arrows) by an EB1-GFP comet (arrowheads); and (ii) the bidirectional movement of MT1-mCherry vesicles (arrows) along the microtubules (arrowheads). (**B**) Kymographs showing the spatiotemporal correlation between MT1-mCherry and EB1-GFP signals along K1 and K2 lines indicated in the merge image. The maximal projection of MT1-mCherry and EB1-GFP signals was constructed from 40 frames in a 40 s time-lapse series. Arrows indicate the examples of lateral displacement of initially stationary MT1-mCherry vesicles after EB1-GFP comets had passed through. (**C**) Representative TIRF-FRAP images showing the local capturing of MT1-mCherry vesicles at AChR clusters. After photobleaching, the recovery of MT1-mCherry signals and their trajectories in two regions of interest indicate (i) MT1-mCherry vesicles (arrows) were transported to and captured at the perforation of AChR clusters; and (ii) two groups of MT1-mCherry vesicles (red and green arrows) were transported to and captured at the same site of AChR cluster periphery over a period of 120 s. (**D**) Kymographs showing the spatiotemporal capture of MT1-mCherry vesicles at AChR clusters. Two kymographs were constructed from 120 time-lapse images along K3 and K4 lines, as indicated in the merge image (top panels in C). Arrowheads and arrows indicate the sites of MT1-mCherry capture at the perforated and peripheral regions of AChR clusters, respectively. Scale bars represent 10 μm, unless stated otherwise.](elife-54379-fig5){#fig5}

To further visualize the directed trafficking and capturing of MT1-MMP vesicles at PLS-associated AChR clusters, we performed TIRF-FRAP experiments on MT1-MMP-mCherry-expressing muscle cells after AChR labeling. The cells with low expression level of MT1-MMP-mCherry were chosen, in which the formation of aneural AChR clusters was largely unaffected. After photobleaching, we detected local capturing of MT1-MMP-mCherry vesicles at the edge of perforations within aneural AChR clusters (white arrows, region 'i' in [Figure 5C](#fig5){ref-type="fig"}), as well as at the edge of AChR cluster periphery (red and green arrows, region 'ii' in [Figure 5C](#fig5){ref-type="fig"}). In kymographs constructed along 'K3' and 'K4' lines, we observed MT1-MMP-mCherry vesicles that were frequently captured at both perforations (arrowheads) and periphery (arrows) of AChR clusters over the 120 s imaging period after photobleaching ([Figure 5D](#fig5){ref-type="fig"}). As both sites are enriched with PLS cortex markers, vinculin and talin (arrowheads in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}), we speculated that PLSs, through the cortex domains, can mediate site-directed capturing of MT1-MMP vesicles for their subsequent surface insertion.

Surface insertion of MT1-MMP is correlated with the formation and remodeling of AChR clusters {#s2-6}
---------------------------------------------------------------------------------------------

As MT1-MMP-mCherry over-expression significantly inhibited the formation of AChR bottom clusters ([Figure 3C](#fig3){ref-type="fig"}), we further used MT1-MMP tagged with a pH-sensitive green fluorescent protein pHluorin (MT1-MMP-pHluorin) to verify if the surface expression of MT1-MMP produces a similar inhibitory effect on AChR clustering. In cultured muscle with low MT1-MMP-pHluorin expression level, MT1-MMP-pHluorin signals were spatially enriched at the perforated regions of aneural AChR clusters (arrow ) and caused only a slight inhibition on aneural AChR clustering ([Figure 6A and B](#fig6){ref-type="fig"}). At high MT1-MMP-pHluorin expression, the formation of AChR bottom clusters was significantly inhibited, leading to sparsely scattered appearance if observed. These data further confirmed that MT1-MMP activity is crucial for the formation of topologically complex AChR clusters by precisely controlling focal ECM degradation at the perforated sites.

To validate the surface localization of MT1-MMP in AChR clusters, we treated MT1-MMP-pHluorin-expressing muscle cells with a non-permeable buffer at pH 5.0 and observed a large reduction in MT1-MMP-pHluorin fluorescence intensity (arrows in [Figure 6C](#fig6){ref-type="fig"}), mimicking the quenching of MT1-MMP-pHluorin signals in acidic vesicular compartments. The signals were then restored after changing the culture medium back to pH 7.8, validating the effectiveness of this probe for visualizing surface localization of MT1-MMP, as it emits bright fluorescence upon surface insertion. Using this probe, we further determined the correlation between surface localization of MT1-MMP and topological remodeling of AChR clusters by monitoring the changes in the same AChR clusters over 24 hr in cultured muscle cells with different expression levels of MT1-MMP-pHluorin ([Figure 6D](#fig6){ref-type="fig"}). It should be noted that muscle cells with low MT1-MMP-pHluorin expression level were chosen to minimize the non-specific effects of exogenous overexpression. In this example, AChR cluster intensity was moderately reduced by 26% after 24 hr in the muscle cell with a very low expression level of MT1-MMP-pHluorin. In contrast, AChR cluster intensity in a muscle cell with a relatively higher (low) MT1-MMP-pHluorin expression showed about 78% reduction during the same period. Quantitative analyses on a pool data of 13 AChR clusters further indicated that MT1-MMP-pHluorin intensity in AChR cluster region was linearly correlated with the change in AChR cluster intensity over the next 24 hr ([Figure 6E](#fig6){ref-type="fig"}). These data indicated the functional role of surface MT1-MMP in promoting the topological remodeling of AChR clusters.

![Spatial delivery of surface MT1-MMP regulates AChR cluster formation and remodeling.\
(**A**) Representative images showing the effects on aneural AChR clustering in cultured muscle cells over-expressing different levels of MT1-MMP-pHluorin (MT1-pHluorin). Arrows indicate the spatial localization of MT1-pHluroin at perforated regions of AChR clusters. (**B**) Quantification on the effects on aneural AChR cluster formation in cultured muscle cells with different levels of MT1-pHluorin over-expression. Cultured muscle cells with average MT1-pHluorin intensity above the cutoff value of \>500 (arbitrary unit) were classified as high expression. n = 150 (Control), 32 (Low MT1-pHluorin level), and 15 (High MT1-pHluorin level) muscle cells from 3 independent experiments. (**C**) Representative sets of images showing the change in MT1-pHluorin fluorescence intensity in response to a sequential switching of various culture media with different pH levels. Arrows indicate the spatial localization of MT1-pHluroin signals in the perforated region of AChR clusters. 8-bit pseudo-color images highlight the change in the relative intensity of MT1-pHluorin. (**D**) Representative sets of time-lapse images showing the extent of AChR cluster remodeling in muscle cells with different MT1-pHluorin expression levels. 8-bit pseudo-color images in the insets highlight the change in the relative intensity of AChR clusters. The percentage values indicate the relative fluorescence intensity of AChR clusters after 24 hr. (**E**) A scatter plot analysis showing the correlation between MT1-pHluorin intensity and the percentage change in AChR intensity over 24 hr in cells with different MT1-pHluorin expression levels. The black line indicates a linear correlation. R = −0.7188, p=0.0056. n = 13 from 3 independent experiments. (**F**) Representative TIRF-FRAP images showing the surface insertion of MT1-pHluorin at AChR clusters in cultured muscle cells. Arrows and arrowheads indicate the spatial insertion of MT1-pHluorin at the perforation and periphery of AChR clusters, respectively. (**G**) Kymographs showing the spatiotemporal insertion of MT1-pHluorin at AChR clusters. Two kymographs were constructed from 180 time-lapse images along the lines of K1 and K2, as indicated in the merge image (left panel). Arrows indicate some newly inserted MT1-pHluorin that were relatively stable, while arrowheads indicate that some were dispersed shortly after surface insertion. (**H**) Quantification on the number of events of MT1-pHluorin surface insertion per unit area (μm^2^) of aneural AChR clusters over the entire time-lapse duration. n = 10 (Control) and 10 (CLASP-MO) muscle cells from 3 independent experiments. Scale bars represent 10 μm, unless otherwise specified. Data are represented as mean ± SEM. One-way ANOVA with Bonferroni's multiple comparisons test (B), Student's t-test (**H**), \*\*, \*\*\* represent p≤0.01 and 0.001 respectively. n.s.: non-significant.](elife-54379-fig6){#fig6}

Next, we performed TIRF-FRAP experiments that aimed to identify the exact locations of MT1-MMP surface insertion at AChR clusters. In this example, strong and discrete MT1-MMP-pHluorin signals re-appeared at the perforation (arrows) and periphery (arrowheads) of AChR clusters at time-points of 118 s and 48 s, respectively, in control muscle cells after photo-bleaching ([Figure 6F](#fig6){ref-type="fig"}). Kymographs constructed along 'K1' and 'K2' lines indicated that some newly inserted MT1-MMP-pHluorin signals were relatively stable (arrows), while some were short-lived but with multiple events of MT1-MMP surface insertion at the same location in AChR clusters (arrowheads) within a short imaging period ([Figure 6G](#fig6){ref-type="fig"}). By quantifying the number of events of MT1-MMP surface insertion, we detected a significant reduction of MT1-MMP-pHluorin surface insertion at AChR clusters in CLASP-MO muscle cells when compared to that in control cells ([Figure 6H](#fig6){ref-type="fig"}). Together with the above data showing the local capture of EB1-GFP comets, this data further confirmed that vesicular trafficking and surface targeting of MT1-MMP are spatially regulated by PLS cortex proteins at the perforation and periphery of AChR clusters through EB1-/CLASP-mediated microtubule capturing mechanisms.

Pharmacological inhibition of MMP activity suppresses the assembly of synaptic AChR clusters and the disassembly of aneural AChR clusters {#s2-7}
-----------------------------------------------------------------------------------------------------------------------------------------

To understand the functional role of PLS-associated MMP activity at developing NMJs, we first examined the effects of MMP inhibitors on ECM degradation and synaptic AChR clustering in *Xenopus* nerve-muscle co-cultures. Along the trail of neurites in contact with the basal membrane of muscle cells (arrows), we observed spatial degradation of fluorescent gelatin-coated substratum and synaptic AChR clustering at the nerve-muscle contacts ([Figure 7A](#fig7){ref-type="fig"}). Like the focal gelatin degradation patterns observed in AChR-poor regions of aneural clusters ([Figure 2A](#fig2){ref-type="fig"}), synaptic AChR clusters at the nerve-muscle contacts were found to be closely associated to, but not perfectly co-localized with, the sites of gelatin degradation, with only 17.15 ± 15% of area in AChR clusters to be associated with gelatin degradation in control co-cultures ([Figure 7C](#fig7){ref-type="fig"}). However, both gelatin degradation and nerve-induced AChR clustering were effectively inhibited by BB-94 or BB-2516 ([Figure 7A and B](#fig7){ref-type="fig"}). Nerve innervation of skeletal muscles involves local signals to initiate the formation of synaptic AChR clusters and global signals to induce the dispersal of aneural AChR clusters ([@bib11]). Thus, we further examined the involvement of MMP activity in the dispersal of aneural AChR clusters induced by latex beads coated with agrin, a heparan sulfate proteoglycan that induces postsynaptic differentiation. Local application of agrin-coated beads to cultured muscle cells is capable of inducing postsynaptic differentiation in a spatiotemporally controllable manner ([@bib23]). In control cells, we detected a gradual dispersal of aneural AChR clusters upon agrin-bead stimulation for 24 hr; however, those clusters in agrin bead-contacted muscle cells were greatly stabilized by BB-94 or BB-2516 ([Figure 7D](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). To determine if agrin stimulation enhances the localization of MT1-MMP in aneural AChR clusters prior to their dispersal, we performed immunostaining experiments, in which we demonstrated an increase of endogenous MT1-MMP signals at aneural AChR clusters upon agrin stimulation ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). These data implicated the important role of MT1-MMP activity in regulating not only the assembly of synaptic AChR clusters at nerve-muscle contacts, but also the disassembly of aneural AChR clusters, at developing NMJs.

![Pharmacological inhibition of MMP activity suppresses the assembly of synaptic AChR clusters and the disassembly of aneural AChR clusters.\
(**A**) Representative images showing the focal degradation of fluorescent gelatin and the formation of nerve-induced AChR clusters along the trails of nerve-muscle contacts (arrows) in control co-cultures, but not in co-cultures treated with MMP inhibitors. To better show the degree of colocalization, merge images were created by overlaying the binary images of AChR and fluorescent gelatin channels after thresholding. Arrowheads in the magnified inset indicate the spatial colocalization between synaptic AChR clusters and gelatin degradation (with only red signals). (**B**) Quantification on the effects of MMP inhibitors on fluorescent gelatin degradation and nerve-induced AChR clustering. n = 30 (Control), 32 (BB-94), and 38 (BB-2516) nerve-muscle pairs from 4 independent experiments. (**C**) Quantification on the degree of colocalization between synaptic AChR clusters and gelatin degradation in nerve-muscle contacts. n = 26 (Control), 36 (BB-94), and 36 (BB-2516) nerve-muscle pairs from 4 independent experiments. Data are represented as mean ± SD. (**D**) Representative time-lapse images showing the effects of MMP inhibitors on the dispersal of aneural AChR clusters upon agrin bead stimulation. 8-bit pseudo-color images highlight the change in fluorescence intensity of aneural AChR clusters over 24 hr in different conditions. (**E**) A schematic diagram illustrating the preparation of endogenous agrin tracks on ECL-coated substratum for inducing synaptic AChR clustering in cultured muscle cells. (**F**) Representative images showing the inhibitory effects of MMP inhibitors on synaptic AChR clustering induced by endogenous agrin tracks. The location of agrin tracks was visualized by agrin immunostaining and then confirmed if neurites were not found in the phase contrast images. Dotted lines outline the periphery of muscle cells. (**G**) Quantification on the effects of MMP inhibitors on synaptic AChR clustering induced by endogenous agrin tracks. n = 30 (Control), 27 (BB-94), and 22 (BB-2516) muscle cells from 3 independent experiments. Scale bars represent 10 μm. Data are represented as mean ± SEM, unless otherwise specified. One-way ANOVA with Dunnett's multiple comparisons test, \*, \*\*, \*\*\* represent p≤0.05, 0.01, and 0.001 respectively.](elife-54379-fig7){#fig7}

In contrast to nerve-induced AChR clustering, we noted that MMP inhibitors did not significantly affect the formation of AChR clusters induced by agrin beads ([Figure 7---figure supplement 1B and C](#fig7s1){ref-type="fig"}). As the latex beads were coated with a high amount of exogenous recombinant agrin, and they were placed on the top surface of cultured muscle cells, it remained unclear if MMP activity regulates synaptic AChR clustering induced by the physiological amount of agrin and in the presence of different ECM proteins. Therefore, we further developed an 'endogenous agrin track' assay ([Figure 7E](#fig7){ref-type="fig"}), by which we examined the effects of MMP inhibitors on synaptic AChR clustering in muscle cells cultured on ECL-coated substratum with endogenous agrin tracks. Using this assay, both BB-94 and BB-2516 were found to significantly inhibit the formation of synaptic AChR clusters induced by the endogenous agrin tracks ([Figure 7F and G](#fig7){ref-type="fig"}), consistent with our data on nerve-induced AChR clustering.

Postsynaptic MT1-MMP is a regulator of NMJ development {#s2-8}
------------------------------------------------------

To identify the postsynaptic functions of MT1-MMP in NMJ development, antisense MO was used to knock down the endogenous expression of MT1-MMP specifically in muscle cells and then co-cultured with wild-type (WT) spinal neurons. The efficiency of MO-mediated knockdown of endogenous MT1-MMP protein level in *Xenopus* embryos was validated by western blot analysis ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Pre-existing and newly inserted AChR molecules were differentially labeled by α-bungarotoxin conjugated with different fluorophores according to our previously established protocol ([@bib23]). In short, we first labeled all pre-existing AChR molecules with tetramethylrhodamine-conjugated α-bungarotoxin in muscle cells. After plating the spinal neurons for 1 day, the newly synthesized AChRs can then be labeled with Alexa Fluor 488-conjugated α-bungarotoxin. In control co-cultures, both pre-existing and newly inserted AChR signals were detected at the nerve-muscle contact sites ([Figure 8A](#fig8){ref-type="fig"}), suggesting that both receptor pools contribute to the assembly of nerve-induced synaptic AChR clusters. Importantly, MT1-MMP knockdown caused a significant reduction, but not a complete inhibition, of nerve-induced AChR clustering in the chimeric co-cultures of MT1-MMP MO muscles with WT neurons ([Figure 8A and B](#fig8){ref-type="fig"}). This could be explained by the partial knockdown of endogenous MT1-MMP protein level ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}) and/or the recruitment of diffuse AChRs to the nerve-muscle contacts via MT1-MMP-independent processes. Intriguingly, both pre-existing and newly inserted AChRs at the nerve-muscle contacts were equally affected in the chimeric co-cultures of MT1-MMP MO muscles with WT neurons ([Figure 8C and D](#fig8){ref-type="fig"}). To rule out the possible off-target effects of MT1-MMP MO, we next performed rescue experiments by overexpressing MT1-MMP-mCherry (MT1-mCherry) in MT1-MMP knockdown (MT1-MO) muscle cells. In the chimeric co-cultures of MT1-MO + MT1-mCherry muscles with WT neurons, we found that the percentage of nerve-muscle contacts with AChR clusters was largely returned to the level comparable with the control groups, and both pre-existing and newly inserted AChRs were detected at the nerve-muscle contacts ([Figure 8](#fig8){ref-type="fig"}). These data suggested that postsynaptic MT1-MMP regulates both the surface delivery of newly synthesized AChR molecules and the redistribution/recruitment of pre-existing AChR molecules (from either aneural AChR clusters or diffuse AChRs on muscle surface) during the assembly of nerve-induced postsynaptic specializations at developing NMJs.

![Postsynaptic MT1-MMP is required for nerve-induced AChR clustering.\
(**A**) Representative images showing the localization of pre-existing and newly inserted AChR clusters at nerve-muscle contacts (arrows) in control co-cultures (WT (M)) and in the chimeric co-cultures of wild-type neurons and muscle cells with control morpholino (Control MO (M)), MT1-MMP-MO (MT1-MO (M)), or MT1-MMP-mCherry and MT1-MMP-MO (MT1-mCherry + MT1-MO (M)) muscles. Fluorescent dextran indicates the muscle cells derived from MO-injected embryos. 8-bit pseudo-color images highlight the relative fluorescence intensity of pre-existing and newly inserted AChR signals. (**B**) Quantification on the percentage of nerve-muscle contacts with AChR clusters in control nerve-muscle co-cultures and in different chimeric co-cultures. n = 127 (WT), 120 (Control MO), 146 (MT1-MO), or 34 (MT1-mCherry + MT1-MO) nerve-muscle pairs from 3 independent experiments. (**C**) Quantification on the intensity of pre-existing AChR signals per unit length of nerve-muscle contacts in control co-cultures and in different chimeric co-cultures. n = 29 (WT), 30 (Control MO), 32 (MT1-MO), or 23 (MT1-mCherry + MT1-MO) nerve-muscle pairs from 4 independent experiments. (**D**) Quantification on the intensity of newly inserted AChR signals per unit length of nerve-muscle contacts in control co-cultures and in different chimeric co-cultures. n = 24 (WT), 23 (Control MO), 25 (MT1-MO), or 19 (MT1-mCherry + MT1-MO) nerve-muscle pairs from 3 independent experiments. Scale bar represents 10 μm. Data are represented as mean ± SEM. One-way ANOVA with Sidak's multiple comparisons test, \*, \*\*, \*\*\* represent p≤0.05, 0.01, and 0.001 respectively. n.s.: non-significant.](elife-54379-fig8){#fig8}

MT1-MMP regulates the recruitment of AChR molecules from aneural to synaptic clusters {#s2-9}
-------------------------------------------------------------------------------------

To determine if aneural AChR clusters contribute to the formation of NMJs, we next performed laser-based photobleaching experiments to differentiate the recruitment of AChR molecules from aneural clusters versus diffuse AChRs for the assembly of nerve-induced synaptic AChR clusters ([Figure 9A](#fig9){ref-type="fig"}). Without photobleaching, AChR signals were prominently detected at the nerve-muscle contact sites. The formation of nerve-induced synaptic AChR clusters was accompanied by the dispersal of aneural AChR clusters after 1 day in co-culture. In the experimental groups with photobleaching of aneural AChR clusters before co-culturing with the spinal neurons, we detected a significant reduction in AChR signals, which were contributed from diffuse AChRs only, at the nerve-muscle contacts in comparison to the control groups without photobleaching ([Figure 9B and C](#fig9){ref-type="fig"}). These results provided compelling evidence to support the hypothesis that AChR molecules from aneural clusters serve as a major source for the assembly of synaptic AChR clusters.

![Postsynaptic MT1-MMP is required for the recruitment of aneural AChR clusters to the assembly of synaptic AChR clusters.\
(**A**) A schematic diagram illustrating the use of laser-based photobleaching approach to differentially identify the contribution of aneural AChR clusters and diffuse AChRs for the assembly of nerve-induced synaptic AChR clusters. (**B**) Representative images showing the differential contribution of aneural AChR clusters and diffuse AChRs to nerve-induced synaptic AChR clusters in control co-cultures (WT) and in the chimeric co-cultures of wild-type neurons and muscle cells with control MO or MT1-MMP MO. Yellow boxes (right panels) indicate the region of photobleaching. White boxes show a magnified view of nerve-muscle contacts in 1-d old co-cultures. Dotted lines highlight the periphery of muscle cells. Fluorescent dextran signals in the insets indicate the muscle cells with microinjected MO. 8-bit pseudo-color images highlight the relative fluorescence intensity of AChR signals. Arrows indicate synaptic AChR clusters at nerve-muscle contact sites. Arrowheads indicate the original location of aneural AChR clusters. (**C**) Quantification on the intensity of AChR signals at the nerve-muscle contacts in control co-cultures and in chimeric co-cultures either with or without photobleaching. The control groups without photobleaching indicate the contribution from aneural AChR clusters + diffuse AChRs, n = 15 (WT), 9 (Control MO), and 9 (MT1-MMP MO) nerve-muscle pairs from 3 independent experiments. The experimental groups with photobleaching of aneural AChR clusters indicate the contribution from diffuse AChRs only, n = 23 (WT), 13 (Control MO), and 8 (MT1-MMP MO) nerve-muscle pairs from 3 independent experiments. Scale bars represent 10 μm. Data are represented as mean ± SEM. Two-way ANOVA with Sidak's multiple comparison test, \*, \*\* represent p≤0.05 and 0.01 respectively.](elife-54379-fig9){#fig9}

To further investigate the involvement of MT1-MMP in the recruitment of AChRs from aneural to synaptic clusters, we performed the same photobleaching experiments using chimeric co-cultures composed of either control MO or MT1-MMP MO muscle cells with WT spinal neurons ([Figure 9B](#fig9){ref-type="fig"}). In the chimeric co-cultures with control MO muscle cells, both aneural clustered and diffuse AChRs were recruited to the nerve-muscle contacts at a level comparable to the wild-type co-cultures. However, knockdown of MT1-MMP in muscles significantly suppressed the recruitment of AChR molecules from aneural to synaptic clusters, while the recruitment from diffuse AChRs was unaffected ([Figure 9C](#fig9){ref-type="fig"}). Consistent with the data above ([Figure 7D](#fig7){ref-type="fig"}), we found that knockdown of muscle MT1-MMP caused a higher stability of aneural AChR clusters against nerve-induced dispersal (arrowheads, lower left panels in [Figure 9B](#fig9){ref-type="fig"}). Interestingly, after photobleaching of aneural AChR clusters in the chimeric co-cultures with MT1-MMP MO muscles cells, the fluorescence intensity of photobleached aneural AChR clusters was partially recovered after 1 day in co-culture (arrowheads, lower right panels in [Figure 9B](#fig9){ref-type="fig"}). These results suggested that diffuse AChRs were constantly recruited to aneural AChR clusters that were stabilized by muscle MT1-MMP knockdown, presumably through the diffusion-trap mechanisms in which diffuse AChRs can be immobilized by molecular scaffolds associated with the stable aneural AChR clusters ([@bib15]). Taken together, our data further supported that muscle MT1-MMP plays a dual-functional role in regulating the formation and dispersal of synaptic and aneural AChR clusters, respectively.

Loss of MT1-MMP impairs AChR re-distribution and clustering at developing NMJs in vivo {#s2-10}
--------------------------------------------------------------------------------------

To further investigate if MT1-MMP is required for NMJ development in vivo, we first performed immunostaining experiments to examine the localization of endogenous MT1-MMP at mature NMJs in rat soleus muscles. MT1-MMP was found to be highly enriched at the NMJs ([Figure 10A](#fig10){ref-type="fig"}). On the other hand, some immunostaining signals, which were partly contributed by intracellular MT1-MMP proteins, were also observed outside of the AChR cluster regions, further indicating that the precise control of MT1-MMP trafficking and surface insertion is required for mediating local ECM degradation at NMJs. The specificity of MT1-MMP antibody was validated by pre-incubating the antibody with recombinant MT1-MMP proteins, which caused a large reduction of immunostaining signals at the NMJs. To further determine whether MT1-MMP is postsynaptically localized, a denervation experiment on adult rat soleus muscle was performed ([Figure 10B](#fig10){ref-type="fig"}). In 4 days after sciatic nerve cut, we observed only a slight reduction in MT1-MMP signals at the NMJs of denervated muscles, suggesting that MT1-MMP is expressed primarily in postsynaptic muscles.

![MT1-MMP is a regulator of NMJ development in vivo.\
(**A**) Representative confocal images showing the localization of endogenous MT1-MMP at perforations of synaptic AChR clusters (arrows, top panels) in longitudinal cryosections of adult rat soleus muscles. The specificity of MT1-MMP antibody was verified by pre-incubating anti-MT1-MMP primary antibody with recombinant human MT1-MMP protein (rhMT1-MMP, bottom panels). Neurofilament (NF) was used as a neuronal marker. (**B**) Representative confocal images showing the postsynaptic localization of MT1-MMP at NMJs as demonstrated by the surgical denervation experiment. Staining of AChR, MT1-MMP, and presynaptic marker (NF and synaptophysin (Syn)) was performed using cross sections from adult rat soleus muscles either without (top panels) or with sciatic nerve cut after 4 days (bottom panels). (**C**) Representative confocal images showing aneural versus synaptic AChR clusters in whole-mount diaphragms from wild-type (WT) control and MT1-MMP^-/-^ mice at E13.5 (left panels) and E18.5 (right panels). Whole-mount tissues were stained for AChR and NF. The superimposed 3D reconstruction images were generated by z-stack images using Imaris. Synaptic AChR clusters (yellow) were identified when signals of AChR and NF overlapped with each other, whereas other AChR signals (red) represent aneural AChR clusters. (**D--G**) Quantification on the density of aneural (**D**) versus synaptic (**E**) AChR clusters, the width of end-plate bands (**F**), and the length of axonal branches (**G**) in diaphragm muscles between wild-type and MT1-MMP^-/-^ mouse embryos at E13.5 and E18.5. n = 4 (E13.5, WT) and 5 (E13.5, MT1-MMP^-/-^), 5 (E18.5, WT), and 3 (E18.5, MT1-MMP^-/-^) embryos from three independent experiments. Scale bars represent 10 μm (**A**) or 100 μm (**C**). Data are represented as mean ± SEM. Two-way ANOVA with Sidak's multiple comparison test (**D and E**), Student's t-test (**F and G**), \*, \*\*, \*\*\* represent p≤0.05, 0.01, and 0.001 respectively. n.s.: non-significant.](elife-54379-fig10){#fig10}

Next, we examined the patterns of AChR clusters in embryonic diaphragm muscles between WT and MT1-MMP-deficient mice, which was previously established ([@bib33]; [@bib52]). Specifically, diaphragms from WT and MT1-MMP^-/-^ mice at E13.5 and E18.5 were dissected and whole-mount stained for AChR and phrenic nerve. Aneural and synaptic AChR clusters were quantified based on whether the clusters were in direct contacts with the phrenic nerve branches. The endplate band width, which represents the zone of AChR cluster formation in the center of muscle fibers innervated by the phrenic nerve, was also measured. At E13.5, MT1-MMP^-/-^ mice showed a significantly higher density of aneural AChR clusters than the age-matched WT mice, but the density of synaptic AChR clusters was largely unchanged at this stage ([Figure 10C-E](#fig10){ref-type="fig"}). At E18.5, we observed a significant reduction in the density of synaptic AChR clusters and endplate band width in MT1-MMP^-/-^ mice compared to those in the WT mice ([Figure 10E-F](#fig10){ref-type="fig"}), indicating that synaptic AChR clusters formed in the knockout mice were immature with the altered number and density. Interestingly, the phrenic nerve in MT1-MMP^-/-^ mice also exhibited abnormal phenotype with less axonal defasciculation and arborization in the diaphragm muscles ([Figure 10C and G](#fig10){ref-type="fig"}), suggesting either the retrograde signaling of postsynaptic MT1-MMP or a possible role of neuronal MT1-MMP in regulating axonal growth and differentiation. Together, these findings further validated our in vitro data showing an important function of MT1-MMP in regulating the recruitment of aneural AChR clusters for the assembly of postsynaptic specializations at developing NMJs in vivo.

Discussion {#s3}
==========

At developing NMJs, AChR pre-patterns can be formed in muscle fibers without motor innervation in vivo ([@bib25]; [@bib47]), suggesting that muscle-intrinsic mechanisms are sufficient to regulate the initial formation of aneural AChR clusters. In this study, we showed that the formation of topologically complex aneural AChR clusters in *Xenopus* muscle cells requires several key ECM proteins ([Figure 1](#fig1){ref-type="fig"}). As ECM proteins can be secreted and deposited by skeletal myofibers and other different cell types that constitute the synaptic basal lamina at developing NMJs, the initial formation of AChR clusters may not be solely mediated by muscle-intrinsic mechanisms.

The synaptic basal lamina is unique in composition, containing factors capable of inducing the assembly of synaptic specializations in both presynaptic and postsynaptic membranes, such as laminin-421, collagen IV/VI/XIII, heparan sulfate proteoglycans (e.g. agrin and perlecan), and other ubiquitously expressed ECM proteins (e.g. laminin-111, fibronectin and entactin/nidogen) ([@bib5]; [@bib8]; [@bib22]; [@bib36]). Among the different factors in the synaptic basal lamina, agrin plays the central role in the formation of postsynaptic specializations by activating the Lrp4/MuSK complex ([@bib19]; [@bib50]). In this study, we observed extensive degradation of ubiquitously expressed ECM proteins, including gelatin and laminin-111, at AChR clusters ([Figure 2A-D](#fig2){ref-type="fig"}). A previous study suggested that MMP-3 is implicated for the removal of agrin from synaptic basal lamina at adult NMJs ([@bib42]). In this study, however, the pattern and intensity of endogenous agrin tracks were largely unaffected by MMP inhibitors ([Figure 7F](#fig7){ref-type="fig"}), ruling out the possible proteolytic degradation of secreted agrin by MT1-MMP activity at developing NMJs. Therefore, we hypothesize that PLS-associated MMP activity focally degrades different ubiquitously expressed ECM proteins, which clear the zone at the nascent synaptic basal lamina for the deposition of other secreted synaptogenic factors (e.g. agrin or neuregulin) and/or dismantle the extracellular anchorage of AChR molecules on ECM proteins that allow aneural clusters to undergo dispersal and re-distribution upon nerve induction ([Figure 11](#fig11){ref-type="fig"}). Interestingly, agrin can serve as a mechanotransduction signal, which may transduce ECM and cellular rigidity signals to the Hippo pathway effector YAP, that requires both the Lrp4-MuSK signaling and integrin-focal adhesion signaling in liver cancer cells ([@bib6]). Importantly, muscle YAP mutation was found to impair the formation of NMJs and to inhibit NMJ regeneration after nerve injury ([@bib51]). Therefore, the possible crosstalk between ECM-integrin and agrin-Lrp4-MuSK signaling pathways in regulating the postsynaptic differentiation at NMJs remains to be investigated.

![Working model on site-directed vesicular trafficking and surface delivery of MT1-MMP to regulate AChR cluster formation and remodeling.\
(**A**) Schematic diagram showing the proposed mechanisms underlying site-directed MT1-MMP trafficking and surface insertion for the regulation of focal ECM degradation and the recruitment of ECM-induced bottom aneural AChR clusters to nerve-induced synaptic clusters at developing NMJs. (**B**) Logical flow diagram proposing key events in the mechanistic role of ECM-induced PLS assembly in MT1-MMP trafficking and surface insertion, and the functional role of MT1-MMP-mediated ECM degradation in postsynaptic development. The relevant data presented in the main figures that support each of the individual proposed events are highlighted in red.](elife-54379-fig11){#fig11}

PLSs are highly dynamic actin-rich organelles found in transformed fibroblasts and many other motile or invasive cells. We detected several typical core and cortex markers of PLSs that were highly concentrated at perforated AChR clusters ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}), further confirming the presence of PLSs in primary myotomal muscle cultures. Intriguingly, PLS cortex proteins, like vinculin and talin, were enriched not only at the perforated regions, but also at the periphery, of aneural AChR clusters ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). At those sites, some MT1-MMP-mCherry signals were captured ([Figure 5D](#fig5){ref-type="fig"}), and some MT1-MMP-pHluorin signals were spatially recovered after photobleaching ([Figure 6F](#fig6){ref-type="fig"}). These data suggested that PLS cortex proteins may capture MT1-MMP-containing vesicles and facilitate their surface insertion at the perforation and periphery of AChR clusters. It is important to note that both signals of MT1-MMP immunostaining ([Figure 3A](#fig3){ref-type="fig"}) and MT1-MMP-mCherry overexpression ([Figure 5](#fig5){ref-type="fig"}) were not selectively localized to aneural AChR clusters, as both surface and intracellular MT1-MMP at the vesicular compartments were highlighted. In contrast, the localization patterns of MT1-MMP-pHluroin at a low expression level ([Figure 6A](#fig6){ref-type="fig"}) and fluorescent gelatin degradation ([Figure 2A](#fig2){ref-type="fig"}) were primarily restricted to the perforated AChR clusters. These results suggested that the vesicular trafficking and surface insertion of MT1-MMP is precisely controlled to mediate ECM degradation during NMJ formation.

Microtubules are important cytoskeletal structures for intracellular transport of proteins. EB1, a key regulator of the plus-end-tracking protein complex, functions to modulate microtubule dynamics and interaction with other intracellular organelles. Although endogenous EB1 comets can be found in the entire cell, they are highly enriched at the sites specialized for efficient coordination of cargo transport and release, such as focal adhesions and NMJs ([@bib28]; [@bib35]). Direct interactions between EB1 and other microtubule plus-end-tracking proteins (CLASPs and CLIP-170) are implicated in the 'recruitment mechanism', by which EB1 functions to search-and-capture post-Golgi vesicles and to spatially capture microtubules at the cell cortex ([@bib43]). LL5β, one of the PLS cortex proteins, is localized at the postsynaptic membrane to serve as a corral for AChRs within the clusters ([@bib20]). Interestingly, LL5β and CLASP1 interact with microtubules for directing the vesicular trafficking of different proteins to the postsynaptic membrane of NMJs ([@bib3]) and to the focal adhesions ([@bib39]). In this study, antisense MO-mediated knockdown of endogenous *Xenopus* CLASP, the homolog of mammalian CLASP1, in cultured muscle cells significantly reduced the local capture of microtubules at AChR clusters, as reflected by the increased average speed of EB1-GFP comets within AChR regions ([Figure 4C](#fig4){ref-type="fig"}). It was also noted that microtubule plus-end-tracking proteins are capable to hop on and off from microtubule ends ([@bib12]), thus we cannot exclude the possibility of EB1-GFP signal recovery at the photobleached region that may be partly contributed by the exchange of EB1-GFP molecules between the free and microtubule-bound pools. Given that MT1-MMP surface insertion at aneural AChR clusters was significantly inhibited in CLASP-MO muscle cells ([Figure 6H](#fig6){ref-type="fig"}), we therefore hypothesize that EB1-mediated microtubule capturing mechanisms can be regulated by PLSs at both cortex (adhesion molecule-based) and core (actin-based) domains via CLASP-dependent and -independent manner respectively, which is in agreement with other previous studies demonstrating the involvement of microtubule-dependent vesicular transport in AChR clustering ([@bib3]; [@bib27]; [@bib35]).

It has long been suggested that innervation of the skeletal muscle involves local signaling to initiate the formation of synaptic AChR clusters at the nerve-muscle contacts, and global signaling to induce the dispersal of aneural AChR clusters ([@bib11]). However, a compelling evidence supporting that aneural AChR clusters serve as source for synaptic AChR clusters at developing NMJs is still lacking. In this study, we used laser-based photobleaching approach to demonstrate the differential contribution of AChR molecules from aneural clusters and diffuse AChRs for the assembly of nerve-induced synaptic AChR clusters ([Figure 9](#fig9){ref-type="fig"}). In agreement with previous studies ([@bib2]; [@bib10]), most nerve contacts in *Xenopus* primary cultures are located at either the basal surface or the lateral side of muscle cells, which are influenced by MMP-mediated proteolytic degradation of ECM proteins. Importantly, we demonstrated that the recruitment of AChRs from aneural clusters, but not diffuse AChRs, is mediated by MT1-MMP-dependent processes. While MT1-MMP knockdown caused a significant inhibition in synaptic AChR clustering at the nerve-muscle contacts, it is intriguing to note that diffuse AChRs were constantly recruited to aneural AChR clusters that were stabilized by MT1-MMP knockdown ([Figure 9B](#fig9){ref-type="fig"}). This recruitment may be mediated by the diffusion-trap mechanism, in which diffuse AChRs can be tethered to molecular scaffolds associated with the stable aneural AChR clusters ([@bib15]). Therefore, we hypothesize that MT1-MMP facilitates the disassembly of extracellular (e.g. ECM proteins) and/or intracellular (e.g. cytoskeletal proteins) molecular scaffolds that are tightly associated with aneural AChR clusters, such that AChR molecules from dispersing aneural clusters can be recruited to synaptic clusters in response to nerve induction. In a minority of cases, some aneural and nerve-induced AChR clusters can be found at the top muscle surface, where no ECM proteins are directly involved. Particularly, those top aneural AChR clusters are spontaneously formed with possibly no physiological relevance, whether MT1-MMP regulates the formation and remodeling of ECM-independent top AChR clusters remains unknown. Collectively, our present study further supported that postsynaptic MT1-MMP plays a dual-functional role in regulating the formation and dispersal of synaptic and aneural AChR clusters, respectively, via focal ECM degradation.

MT1-MMP is the best characterized and the most prevalent isoform of the large MMP family, including membrane-type or soluble MMPs. MT1-MMP deficiency causes myogenic impediments and central nucleation of myofibers, which are typically found in muscular dystrophy ([@bib29]). Besides, MT1-MMP knockout mice develop multiple abnormalities and die between 50--90 postnatal days ([@bib17]), suggesting that the possibility of functional redundancy by other MMP isoforms is low. In this study, we used mutant mice lacking MT1-MMP in all cells and observed that the density of aneural AChR clusters was significantly higher than that in wild-type mice at E13.5 ([Figure 10D](#fig10){ref-type="fig"}), consistent with the in vitro findings on the involvement of MT1-MMP in the recruitment of AChR molecules from aneural to synaptic AChR clusters ([Figure 9](#fig9){ref-type="fig"}). However, at E18.5, the density of aneural AChR clusters between MT1-MMP^-/-^ and wild-type mice was comparable. While aneural AChR clusters in MT1-MMP^-/-^ mice were not recruited to synaptic AChR clusters, they were subjected to the regular metabolic turnover/degradation, leading to the disappearance of aneural AChR clusters at E18.5. This is supported by previous studies showing that the half-life of extra-synaptic AChRs is only about 19 hr, compared with 8--14 days for synaptic AChRs at mature NMJs ([@bib9]; [@bib40]). On the other hand, reduced synaptic AChR density in MT1-MMP^-/-^ mice ([Figure 10E](#fig10){ref-type="fig"}) is attributed by (1) significantly declined recruitment of AChR molecules from aneural clusters, and (2) reduced amount of newly inserted AChRs into the postsynaptic regions. These data provided a solid validation of our in vitro findings that demonstrate the important role of MT1-MMP in regulating the recruitment of pre-existing and newly inserted AChRs to the nerve-muscle contact sites ([Figure 8](#fig8){ref-type="fig"}). It is also important to note that the phrenic nerve in MT1-MMP^-/-^ mice showed a significant reduction of axonal growth and arborization in the diaphragm muscles at both E13.5 and E18.5 ([Figure 10G](#fig10){ref-type="fig"}). This phenotype on defects in axonal growth could be explained by the retrograde signaling initiated by postsynaptic MT1-MMP, which could mediate the extracellular cleavage of Lrp4 to generate ecto-Lrp4 fragments that activate agrin signaling in trans ([@bib46]). In fact, Lrp4 is also considered as a retrograde signal to induce presynaptic differentiation in vivo ([@bib49]). Alternatively, postsynaptic MT1-MMP could also mediate the proteolytic conversion of proBDNF to mature BDNF ([@bib18]) that promotes neuronal survival and outgrowth in cultured neurons ([@bib31]). Nevertheless, by using the whole-body MT1-MMP knockout mice in the present study, we cannot rule out the possible secondary effects on postsynaptic AChR clustering and remodeling that are contributed by the axonal growth and presynaptic differentiation defects in the absence of neuronal MT1-MMP. Therefore, our future studies plan to develop muscle-specific inducible MT1-MMP knockout animal models to further understand how muscle MT1-MMP controls the formation and maturation of NMJs in vivo. Particularly, it would be of great interest to address whether synaptic maturation, as reflected by the plaque-to-pretzel topological transition of AChR clusters during the early postnatal stages in mice, is critically driven by neuronal or muscle MT1-MMP.

From a clinical perspective, increased serum levels of several MMPs have been identified in patients with myasthenia gravis, an autoimmune neuromuscular disease ([@bib16]). As inhibiting MMP activity could greatly stabilize aneural AChR clusters against spontaneous and nerve-induced dispersal ([Figure 2I](#fig2){ref-type="fig"} and [Figure 7D](#fig7){ref-type="fig"}), it would be interesting to test if manipulating muscle MT1-MMP expression level or its activity can suppress the pathogenic action in causing NMJ disassembly using our recently established *Xenopus* cell-based assay for investigating the pathogenesis of myasthenia gravis ([@bib7]; [@bib48]). Given the physiological and pathophysiological roles of MMPs at the NMJs, understanding the cell biology of MT1-MMP trafficking and surface delivery in this study may provide additional insight into the regulation of synaptic function and dysfunction by modulating MMP trafficking and activity in neuromuscular development and diseases.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species) or resource   Designation                                                     Source or reference                                     Identifiers                                                          Additional information
  ------------------------------------ --------------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------
  Gene (*X. laevis*)                   MT1-MMP                                                         Xenbase                                                 XB-GENE-485647                                                       

  Genetic reagent (*M. musculus*)      MT1-MMP^-/-^                                                    Professor Zhongjun Zhou (HKU) [@bib33]                                                                                       \-

  Cell line (*M. musculus*)            C2C12, Mouse immortalized myoblast                              ATCC                                                    Cat\#: CRL-1772,\                                                    From ATCC; Cell identity has been confirmed by STR profiling and cell line was found to be free of *Mycoplasma*.
                                                                                                                                                               RRID:[CVCL-0188](https://scicrunch.org/resolver/CVCL-0188)           

  Biological sample (*X. laevis*)      Primary muscle and neuronal culture                             *Xenopus* 1                                                                                                                  

  Biological sample (Rat)              Rat soleus muscle                                               Laboratory Animal Unit (HKU)                            \-                                                                   Sprague Dawley

  Antibody                             Anti-β-tubulin                                                  Developmental Studies Hybridoma Bank                    Cat\#: 6G7-s,\                                                       IF (1:1000)
                                                                                                                                                               RRID:[AB_528497](https://scicrunch.org/resolver/AB_528497)           

  Antibody                             Anti-α-tubulin                                                  Sigma-Aldrich                                           Cat\#: T6074,\                                                       WB (1:2000)
                                                                                                                                                               RRID:[AB_477582](https://scicrunch.org/resolver/AB_477582)           

  Antibody                             Anti-Agrin                                                      Developmental Studies Hybridoma Bank                    Cat\#: 6D2,\                                                         IF (1:100)
                                                                                                                                                               RRID:[AB_528071](https://scicrunch.org/resolver/AB_528071)           

  Antibody                             Anti-ADF/cofilin                                                Dr James Bamburg (Colorado State University) [@bib23]                                                                        IF (1:500)

  Antibody                             Anti-β-actin                                                    Sigma-Aldrich                                           Cat\#: A2228,\                                                       WB (1:1000)
                                                                                                                                                               RRID:[AB_476697](https://scicrunch.org/resolver/AB_476697)           

  Antibody                             Anti-Cortactin                                                  Santa Cruz Biotechnology                                Cat\#: sc11408,\                                                     IF (1:500)
                                                                                                                                                               RRID:[AB_2088281](https://scicrunch.org/resolver/AB_2088281)         

  Antibody                             Anti-CLASP1                                                     Abcam                                                   Cat\#: ab85919                                                       WB (1:250)

  Antibody                             Anti-EB1                                                        BD Biosciences                                          Cat\#: 610534,\                                                      IF (1:100)
                                                                                                                                                               RRID:[AB_397891](https://scicrunch.org/resolver/AB_397891)           

  Antibody                             Anti-Laminin                                                    Thermo Fisher Scientific                                Cat\#: PA516287,\                                                    IF (1:100)
                                                                                                                                                               RRID:[AB_10985513](https://scicrunch.org/resolver/AB_10985513)       

  Antibody                             Anti-MT1-MMP                                                    Merck Millipore                                         Cat\#: MAB3328,\                                                     IF (1:100 or 1:50)
                                                                                                                                                               RRID:[AB_570599](https://scicrunch.org/resolver/AB_570599)           

  Antibody                             Anti-MT1-MMP                                                    Merck Millipore                                         Cat\#: AB6005,\                                                      WB (1:1000), a gift from Dr Timothy Gomez (University of Wisconsin-Madison)
                                                                                                                                                               RRID:[AB_10618742](https://scicrunch.org/resolver/AB_10618742)       

  Antibody                             Anti-MT1-MMP                                                    Santa Cruz Biotechnology                                Cat\#: sc-373908                                                     IF (1:100)

  Antibody                             Anti-NF200                                                      Sigma-Aldrich                                           Cat\#: N4142,\                                                       IF (1:500 or 1:1000)
                                                                                                                                                               RRID:[AB_477272](https://scicrunch.org/resolver/AB_477272)           

  Antibody                             Anti-Paxillin                                                   Biolegend                                               Cat\#: 624001,\                                                      IF (1:100)
                                                                                                                                                               RRID:[AB_2300550](https://scicrunch.org/resolver/AB_2300550)         

  Antibody                             Anti-p34-Arc                                                    EMD Millipore                                           Cat\#: 07--227,\                                                     IF (1:100)
                                                                                                                                                               RRID:[AB_310447](https://scicrunch.org/resolver/AB_310447)           

  Antibody                             Anti-Synaptobrevin 1                                            Synaptic Systems                                        Cat\#: 104002,\                                                      IF (1:300)
                                                                                                                                                               RRID:[AB_887807](https://scicrunch.org/resolver/AB_887807)           

  Antibody                             Anti-Synaptophysin                                              Abcam                                                   Cat\#: ab32127,\                                                     IF (1:1000)
                                                                                                                                                               RRID:[AB_2286949](https://scicrunch.org/resolver/AB_2286949)         

  Antibody                             Anti-Talin                                                      Biolegend                                               Cat\#: T3287,\                                                       IF (1:100)
                                                                                                                                                               RRID:[AB_477572](https://scicrunch.org/resolver/AB_477572)           

  Antibody                             Anti-Vinculin                                                   Sigma-Aldrich                                           Cat\#: V4505,\                                                       IF (1:100)
                                                                                                                                                               RRID:[AB_477617](https://scicrunch.org/resolver/AB_477617)           

  Recombinant DNA reagent              GFP-EB1                                                         Addgene                                                 RRID:[Addgene_39299](https://scicrunch.org/resolver/Addgene_39299)   

  Recombinant DNA reagent              MT1-MMP-\                                                       Dr Cheng-Han Yu (HKU)                                                                                                        
                                       mCherry                                                                                                                                                                                      

  Recombinant DNA reagent              MT1-MMP-pHluorin                                                Dr Cheng-Han Yu (HKU)                                                                                                        

  Sequence-based reagent               Control morpholino                                              Gene Tools                                              Standard control oligo                                               CCTCTTACCTCAGTTACAATTTATA

  Sequence-based reagent               MT1-MMP morpholino                                              Gene Tools                                              Custom morpholino                                                    CCAGGCTGCTCTCAGAGGCTCCATC

  Sequence-based reagent               CLASP morpholino                                                Gene Tools                                              Custom morpholino                                                    GCCAGTAGTCCATTCCCTGTTCCAT

  Peptide, recombinant protein         α-Bungarotoxin                                                  Thermo Fisher Scientific                                Cat\#: B1601                                                         

  Peptide, recombinant protein         Alexa Fluor 488 Phalloidin                                      Thermo Fisher Scientific                                Cat\#: A12379                                                        

  Peptide, recombinant protein         Alexa Fluor 647 conjugate-α-bungarotoxin                        Thermo Fisher Scientific                                Cat\#: B35450                                                        

  Peptide, recombinant protein         Alexa Fluor 488 conjugate-α-bungarotoxin                        Thermo Fisher Scientific                                Cat\#: B13422                                                        

  Peptide, recombinant protein         Corning Collagen I                                              Fisher Scientific                                       Cat\#: C354249                                                       

  Peptide, recombinant protein         Dextran, Alexa Fluor 488                                        Thermo Fisher Scientific                                Cat\#: D22910                                                        

  Peptide, recombinant protein         Dextran, Alexa Fluor 546                                        Thermo Fisher Scientific                                Cat\#: D22911                                                        

  Peptide, recombinant protein         ECL cell attachment matrix                                      Merck Millipore                                         Cat\#: 08--100                                                       

  Peptide, recombinant protein         Gelatin                                                         Sigma-Aldrich                                           Cat\#: G1393                                                         

  Peptide, recombinant protein         Gelatin From Pig Skin, Fluorescein Conjugate                    Thermo Fisher Scientific                                Cat\#: G13187                                                        

  Peptide, recombinant protein         Gelatin From Pig Skin, Oregon Green 488 Conjugate               Thermo Fisher Scientific                                Cat\#: G13186                                                        

  Peptide, recombinant protein         Laminin from Engelbreth-Holm-Swarm murine sarcoma               Sigma-Aldrich                                           Cat\#: L2020                                                         

  Peptide, recombinant protein         Poly-D-lysine hydrobromide                                      Sigma-Aldrich                                           Cat\#: P1024                                                         

  Peptide, recombinant protein         Recombinant human MT1-MMP                                       R and D Systems                                         Cat\#: 918-MP-010                                                    

  Peptide, recombinant protein         Tetramethylrhodamine α-bungarotoxin                             Thermo Fisher Scientific                                Cat\#: T1175                                                         

  Commercial assay or kit              Alexa Fluor 488 Tyramide SuperBoost Kit, goat anti-mouse IgG    Thermo Fisher Scientific                                Cat\#: B40941                                                        

  Commercial assay or kit              Alexa Fluor 594 Tyramide SuperBoost Kit, goat anti-rabbit IgG   Thermo Fisher Scientific                                Cat\#: B40944                                                        

  Chemical compound, drug              BB-94                                                           ApexBio                                                 Cat\#: A2577-S                                                       

  Chemical compound, drug              Collagenase from Clostridium histolyticum                       Sigma-Aldrich                                           Cat\#: C98191G                                                       

  Chemical compound, drug              Leibovitz\'s L-15 medium                                        Sigma-Aldrich                                           Cat\#: L4386                                                         

  Chemical compound, drug              Marimastat/BB-2516                                              ApexBio                                                 Cat\#: A4049                                                         

  Chemical compound, drug              Sodium borohydride                                              Sigma-Aldrich                                           Cat\#: 452882                                                        

  Software, algorithm                  ZEN 2.3 Blue Edition                                            Carl Zeiss Microscopy                                                                                                        

  Software, algorithm                  Prism 7                                                         GraphPad Software                                                                                                            

  Software, algorithm                  ImageJ 1.52a (Java 1.8.0_66 (64-bit))                           NIH                                                     <https://imagej.nih.gov/ij/>                                         

  Software,\                           Imaris 7                                                        Oxford Instruments                                                                                                           
  algorithm                                                                                                                                                                                                                         

  Software, algorithm                  MetaMorph 7.8.2                                                 Molecular Devices                                                                                                            

  Software, algorithm                  µmanager 1.4                                                    Open Imaging                                                                                                                 

  Other                                CryoStar NX50 Cryostat                                          Thermo Fisher Scientific                                                                                                     

  Other                                DAPI-Fluoromount-G                                              Electron Microscopy Sciences                            Cat\#: 17984--24                                                     

  Other                                Fluoromount-G                                                   Thermo Fisher Scientific                                Cat\#: 00-4958-02                                                    

  Other                                Nanoject II auto-nanoliter injector                             Drummond Scientific                                     Cat\#: 3-000-206A                                                    
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Xenopus* embryonic muscle and nerve-muscle cultures {#s4-1}
----------------------------------------------------

Adult *Xenopus laevis* animals were purchased from *Xenopus* 1. *Xenopus* oocytes were fertilized in vitro, and the embryos were raised in Holtfreter's solution (vol/vol; 60 mM NaCl, 0.6 mM KCl, 0.9 mM CaCl~2~, 0.2 mM NaHCO~3~, pH 7.4) at 22°C. 20--100 pg of DNA constructs encoding MT1-MMP-pHluorin, MT1-MMP-mCherry (a gift from Dr Cheng-Han Yu, The University of Hong Kong) or EB1-GFP (Addgene, 39299) were microinjected into 1 cell stage *Xenopus* embryos using an oocyte injector, Nanoject (Drummond Scientific). GFP- or mCherry-expressing embryos were screened for primary culture preparation, as previously described ([@bib23]; [@bib30]). In short, dorsal parts of wild-type or microinjected embryos at Nieuwkoop and Faber stage 19--22 were dissected. After the enzymatic digestion by collagenase (Sigma, C98191G), myotomal tissues and neural tubes were isolated, followed by dissociation with calcium-magnesium-free solution. The dissociated cells were plated on either coverslips or glass-bottom dishes coated with a mixture of cell attachment substrate, entactin-collagen IV-laminin (ECL) (Millipore, 08--100), or specific ECM proteins including laminin (Sigma, L2020), collagen I (Fisher Scientific, C354249), and gelatin (Sigma, G1393) at 10 µg/ml, or poly-D-lysine (Sigma, P1024) at 100 µg/ml. Cells were maintained in culture medium containing 87% Steinberg's solution (vol/vol; 60 mM NaCl (Sigma, S3014), 0.67 mM KCl (Sigma, P5405), 0.35 mM Ca(NO~3~)~2~ (Sigma, 202976), 0.83 mM MgSO~4~ (Sigma, M2773), 10 mM HEPES (Sigma, H3375), pH 7.4), 10% Leibovitz\'s L-15 medium (Sigma, L4386) (vol/vol), 1% fetal bovine serum (Gibco, 10270) (vol/vol), 1% penicillin/streptomycin (Thermo Fisher Scientific, 15140122) (vol/vol) and 1% gentamicin sulfate (Thermo Fisher Scientific, 15750060) (vol/vol). Muscle cells were kept at 22°C for at least 24 hr to allow cell attachment and development of aneural AChR cluster before treatments, if any. To make nerve-muscle co-cultures, dissociated spinal neurons were plated into 2 d-old muscle cultures and grew for 1 day before imaging. Most of the nerve-contacted sites can be found in the basal membrane of muscle cells on ECM-coated substrates, where the growth cones of spinal neurons are able to crawl and migrate under the muscle cells ([@bib2]; [@bib1]). All experiments involving *Xenopus* frogs and embryos were carried out in accordance with the approved protocol (\#4627--18) by the Committee on the Use of Live Animals in Teaching and Research (CULATR) of The University of Hong Kong.

C2C12 myotube culture {#s4-2}
---------------------

Authenticated C2C12 cell line was purchased from ATCC. Cell identity has been confirmed by STR profiling and cell line was found to be free of Mycoplasma. Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 20% fetal calf serum supplemented with penicillin/streptomycin. Only cells with low passage (\<5) were used in this study. After trypsinization, cells were cultured on glass coverslips coated with 1 mg/ml fluorescent gelatin. To induce myoblast fusion, the culture medium was replaced with the fusion medium containing 2% horse serum (Thermo Fisher Scientific, 16050130) in DMEM supplemented with penicillin/streptomycin.

MT1-MMP knockout mice {#s4-3}
---------------------

MT1-MMP^+/-^ mice in C57BL/6 background were obtained from Motoharu Seiki (Kanazawa University, Japan). In short, exons 1--5 encoding the catalytic domain of MT1-MMP were substituted by LacZ coding sequence ([@bib33]). MT1-MMP^+/-^ mice were backcrossed against C57BL/6 background mice at least 12 times. MT1-MMP^+/-^ mice were mated to produce homozygous MT1-MMP^-/-^ mice, which were confirmed by genotyping. All animal experiments were carried out in accordance with the approved protocol (\#5149--19) by the Committee on the Use of Live Animals in Teaching and Research (CULATR) of The University of Hong Kong.

Rat surgery, tissue harvest, and cryopreservation {#s4-4}
-------------------------------------------------

6-week-old rats received anesthesia by intraperitoneal injection of 130 mg/kg ketamine with 13 mg/kg xylazine. After anesthesia, the left sciatic nerve was exposed with a lateral longitudinal straight incision from the greater trochanter to mid-thigh, and then by blunt dissection between the quadriceps femoris and biceps femoris. After clearing the surrounding connective tissues, the left sciatic nerve was cut with scissors. A sham operation was performed, where the sciatic nerve was exposed, and then the skin was closed immediately afterwards. After the surgery, the rats were returned to the cages in a pathogen-free environment, in a 12 hr light/dark cycle and with water and food ad libitum. Rats were euthanized 4 days after surgery with an overdose of pentobarbital (300 mg/kg). Then, soleus muscles were harvested from the control and denervated rats. After the fixation of the harvested muscles with 2% paraformaldehyde for 30 min, the tissues were then covered with tissue-tek O.C.T. compound (Sakura), and frozen with methanol in liquid nitrogen. Serial longitudinal and cross sections (20 μm thick) were cut in a cryostat microtome at −15°C (CryoStar NX50 Cryostat, Thermo Scientific). All animal experiments were carried out in accordance with the approved protocol by the Committee on the Use of Live Animals in Teaching and Research (CULATR) of The University of Hong Kong.

Morpholino-mediated knockdown of endogenous proteins {#s4-5}
----------------------------------------------------

Knockdown of endogenous proteins in *Xenopus* was achieved by embryonic injection of antisense morpholino oligonucleotides (MO, Gene Tools), which bind to the target mRNA sequence to block its protein translation. The following MO sequences were used in this study: *Xenopus* MT1-MMP MO: 5′-CCAGG CTGCT CTCAG AGGCT CCATC-3′, *Xenopus* CLASP MO: 5'-GCCAG TAGTC CATTC CCTGT TCCAT-3', and standard control MO: 5'-CCTCT TACCT CAGTT ACAAT TTATA-3'. To visualize the presence of MO in the microinjected embryos, MOs were co-injected with Alexa Fluor 488- or Alexa Fluor 546-conjugated dextran (Thermo Fisher Scientific, D22910 or D22911) as a cell lineage tracer. The effectiveness of MO-mediated knockdown of endogenous proteins was validated by Western blot analyses.

Pharmacological treatment {#s4-6}
-------------------------

For the experiments studying the effect of MMP inhibitors on the formation of aneural AChR clusters, 5 μM BB-94 (ApexBio, A2577) or 10 μM Marimastat/BB-2516 (ApexBio, A4049) was added in the culture medium before muscle cell plating. For the experiments studying the nerve-induced or agrin bead-induced AChR clusters, BB-94 or BB-2516 was added to the muscle cultures about 1 hr before adding the spinal neurons or agrin beads.

Live-cell staining {#s4-7}
------------------

Surface AChRs were labeled with 0.1 μM tetramethylrhodamine-, Alexa Fluor 488-, or Alexa Fluor 647-conjugated α-bungarotoxin (Thermo Fisher Scientific, T1175, B13422, or B35450) for 45 min in culture medium, followed by extensive washing with culture medium. To differentially label the pre-existing and newly-inserted pools of AChRs ([@bib23]), the pre-existing AChRs were first labeled with tetramethylrhodamine-conjugated α-bungarotoxin for 45 min, followed by saturating all unlabeled surface AChRs with a high dose (6 μM) of unconjugated α-bungarotoxin (Thermo Fisher Scientific, B1601) for 30 min and then washed extensively with culture medium for at least 3 times. After 1 day, newly inserted AChRs were labeled with 1 μM Alexa Fluor 488-conjugated α-bungarotoxin. Glass coverslips with live cultured cells were then mounted on custom-made sealed chambers containing culture medium for live-cell imaging.

Fluorescent gelatin degradation assay {#s4-8}
-------------------------------------

Glass coverslips (Fisher Scientific, 12-545-82) or glass-bottom dishes (MatTek, P35G-1.5--14 .C-GRID) were coated with 1 mg/ml Oregon Green 488-gelatin or FITC-gelatin (Thermo Fisher Scientific, G13186 or G13187) for 10 min and followed by cross-linking with 0.5% glutaraldehyde (Sigma, G5882) in PBS for 15 min. After that, gelatin-coated coverslips or glass-bottom dishes were treated with 5 mg/ml NaBH~4~ (Sigma, 452882) for 3 min. Dissociated cells were plated on fluorescent gelatin-coated coverslips or glass-bottom dishes and were maintained for different time periods with or without treatment, as specified. All images were taken using the same acquisition settings across different experimental groups. The extent of gelatin degradation was quantified using ImageJ (NIH), by which the mean intensity of fluorescent gelatin signals within the regions of aneural AChR clusters or nerve-muscle contact sites was measured, and then normalized with the mean intensity at the adjacent region in the same cell (except in MT1-MMP-mCherry overexpression experiments, the mean intensity at the adjacent region without cell attachment was used for normalization).

Endogenous agrin track assay {#s4-9}
----------------------------

Dissociated *Xenopus* spinal neurons were first plated on ECL-coated coverslips and cultured for 1 day. Spinal neurons were then digested and removed with 1% Triton X-100 in PBS for 5 min, followed by extensive washing with PBS for at least 5 times for 5 hr. For the experimental groups, pharmacological agents were added into the culture medium before plating the dissociated muscle cells. After 1 day in culture, the location of agrin tracks was visualized by agrin immunostaining (1:100; DSHB, 6D2) and then confirmed if neurites were not found in the phase contrast images.

Fixation and immunostaining of cells and tissues {#s4-10}
------------------------------------------------

Cultured cells were either fixed with 4% paraformaldehyde (Thermo Fisher Scientific, 28908) in PBS for 15 min, followed by permeabilization with 0.5% Triton X-100 in PBS for 10 min or fixed with −20°C 95% ethanol for 5 min. For EB1 immunostaining, muscle cells were fixed with 90% methanol containing 50 mM EGTA at −20°C for 15 min, followed by further fixation with 4% PFA at room temperature for 10 min. The fixed cells were washed extensively with PBS for at least 3 times, followed by blocking overnight with 2% Bovine Serum Albumin (Sigma, A9418) at 4°C. Cells were incubated with primary antibodies, including β-tubulin (1:1000; DSHB, 6G7-s),cortactin (1:500; Santa Cruz Biotechnology, sc11408), paxillin (1:100; Biolegend, 624001), p34-Arc (1:100; Millipore, 07--227), talin (1;100; Sigma, T3287), vinculin (1:100; Sigma, V4504), laminin (1:100; Thermo Fisher Scientific, PA516287), EB1 (1:100; BD Biosciences, 610534), Synaptobrevin/VAMP1 (1:300; Synaptic Systems,104002), MT1-MMP (1:50; Millipore, MAB3328), or ADF/cofilin (1:500; a gift from Dr James Bamburg, Colorado State University) at room temperature for 2 hr, followed by fluorophore-conjugated secondary antibodies (Thermo Fisher Scientific) for 45 min. For MT1-MMP immunostaining, muscle cells were fixed with −20°C 100% methanol for 5 min. Alexa Fluor 488 Tyramide SuperBoost kit (Thermo Fisher Scientific, B40912) was also used. In short, endogenous peroxidase activity was first quenched by incubating the fixed muscle cells with 3% hydrogen peroxide for 1 hr, followed by blocking with 2% Bovine Serum Albumin for 1 hr at room temperature. The fixed muscle cells were then stained with MT1-MMP primary antibody at 4°C overnight, followed by incubating with poly-HRP-conjugated secondary antibody for 1 hr at room temperature. Endogenous MT1-MMP signals were developed by incubating the cells with Alexa Fluor 488 tyramide solution for 5 min. Coverslips were then mounted on glass slides with the anti-bleaching reagent fluoromount-G (Thermo Fisher Scientific, 00-4958-02) for later observation.

For mouse diaphragm muscle tissues, the entire diaphragms were dissected and fixed in 2% paraformaldehyde (PFA) in PBS at room temperature for 1 hr, and then incubated with 0.1 M glycine in PBS for 30 min. The fixed tissues were labeled with 0.1 μM tetramethylrhodamine α-bungarotoxin at room temperature for 30 min. After extensive washing with PBS, tissues were labeled with the primary antibody against neurofilament NF200 (1:1000; Sigma, N4142) in the blocking buffer (1% BSA and 0.3% Triton X-100) at 4°C for 2 days. After extensive washing with 0.5% Triton X-100 in PBS, tissues were incubated overnight with Alexa Fluor 488-conjugated secondary antibody at 4°C. Diaphragm muscles were flat-mounted with fluoromount-G onto glass slides.

For rat soleus muscle tissues, the sections were incubated with 0.1 M glycine for 30 min to remove autofluorescence background and permeabilized by methanol. After blocking with 2% BSA and 0.2% Triton X-100 at room temperature for 2 hr, the sections were labeled with primary antibody against MT1-MMP (1:100; Santa Cruz Biotechnology, sc-373908 and 1:100; Millipore, MAB3328), neurofilament NF200 (1:500; Sigma, N4142), and synaptophysin (1:1000; Abcam, ab32127) for 2 days at 4°C. For MT1-MMP pre-incubation, 1 μg recombinant human MT1-MMP (R and D Systems, 918-MP-010) was pre-incubated with 1 μg MT1-MMP antibody for 2 hr at room temperature. After extensive washing with PBS, the muscle sections were labeled with fluorophore-conjugated secondary antibodies (Thermo Fisher Scientific) for 2 hr at room temperature. Muscle sections were mounted with DAPI-Fluoromount-G (Electron Microscopy Sciences, 17984--24).

Western blot analysis {#s4-11}
---------------------

*Xenopus* embryos at Nieuwkoop and Faber stage 19--22 were homogenized in RIPA buffer in the presence of protease inhibitor cocktail and EDTA, followed by incubation on ice for 5 min. After high-speed centrifugation (15000 x g), the supernatant was collected for protein concentration measurement using a BCA protein assay kit (Thermo Fisher Scientific, 23227). 30 μg protein lysates were used for protein separation by SDS-PAGE, and then blotted onto Immobilon-P membrane (Millipore, IPVH00010). After blocking with 5% non-fat milk in TBST, the blots were probed for the following primary antibodies: MT1-MMP catalytic domain (1:1000; Millipore, AB6005; kindly provided by Professor Timothy Gomez, University of Wisconsin-Madison); CLASP1 (1:250; Abcam, Ab85919); anti-β actin (1:1000; Sigma, A2228); anti-α tubulin (1:2000; Sigma, T6074) overnight at 4°C. After extensive washing with TBST, the blots were reacted with secondary antibodies conjugated with HRP. Signals were detected by ECL western blotting substrate (Thermo Fisher Scientific, 32106), and images were taken by ChemiDoc XRS+ System (Bio-Rad).

Microscopy {#s4-12}
----------

Wide-field fluorescence imaging was performed on inverted microscopes (IX81 or IX83, Olympus) using oil immersion PlanApo 60X NA 1.42 objective lens. On IX81, digital still images were captured by iXon EMCCD camera (Andor) through the software ) through the software cell\^R (Olympus). On IX83, digital still and time-lapse images were captured by ORCA-Flash4.0 LT+ digital CMOS camera (Hamamatsu) through the software MicroManager (Open Imaging) ([@bib13]).

In FRAP experiments, total internal reflection fluorescence (TIRF) mode using Axio TIRF unit fitted in an inverted microscope equipped with oil immersion 100X NA 1.46 DIC objective lens was used. Images were captured through Metamorph (Molecular Devices) by Evolve 512 EMCCD camera (Photometrics). To obtain the baseline of fluorescence intensity before photobleaching, 5 to 6 images were taken with 3 s intervals on cells expressing EB1-GFP and 1 s intervals on cells expressing MT1-MMP-pHluorin or MT1-MMP-mCherry. Photobleaching was performed by using Sapphire laser line (488 nm) with 50% laser intensity, which was kept the same for all FRAP experiments. The photobleaching duration was adjusted based on the signal intensity, ranging from 0.13 to 4.5 s for photobleaching areas between \~ 27 and 34 μm^2^. After photobleaching, images were taken every 3 s until the fluorescence intensity has reached the plateau level.

In the experimental groups involving photobleaching of aneural AChR clusters, interactive bleaching function was used in a confocal microscope (LSM 800, Carl Zeiss) using 20X NA 1.4 DIC objective lens. Photobleaching was performed by using an argon laser (488 nm) with a 100% laser power. Identical settings were applied in all photobleaching experiments. A fluorescence image was taken immediately after photobleaching to ensure the signals of aneural AChR clusters had been completely bleached.

For imaging of mouse diaphragm muscles and rat soleus muscles, multiple tile-scanned, z-stack images were captured on a confocal microscope (LSM 800, Carl Zeiss) using 20X NA 1.4 DIC objective lens or oil immersion 63X NA 1.4 DIC objective lens. Images were captured with 32-channel GaAsp photomultiplier modules through the software ZEN 2.3 (Carl Zeiss). All acquisition settings (i.e. laser intensity and gain) were kept the same for different experimental groups in the same experiment. All acquired images were processed and analyzed by ImageJ (NIH) or Imaris (Bitplane).

Quantification and statistical analyses {#s4-13}
---------------------------------------

To quantify the percentage of AChR top and bottom clusters, muscle cells were first identified in the phase-contrast channel, and then the presence of top or bottom aneural AChR clusters was scored in the fluorescence channel.

To quantify the extent of fluorescent gelatin degradation, the intensity of fluorescent gelatin in the region of interest (ROI, created based on the shape and location of AChR clusters) was measured and then normalized with the intensity of fluorescent gelatin at the adjacent area in the same muscle cell. For experiments involving MT1-MMP-mCherry overexpression, the fluorescent gelatin intensity in the region of AChR clusters was normalized with the intensity in the region without cell attachment.

To quantify the change in the area of aneural AChR clusters, ROI was created at the region of AChR clusters in the image taken at the first time point, and then applied to the images taken at subsequent time points for measuring and calculating the percentage change in cluster size.

To quantify the normalized intensity of aneural AChR clusters, the fluorescence intensity of AChRs in the ROI was first measured in all experimental groups and then normalized to the average AChR intensity in control group of the same experiment.

To quantify the density and speed of EB1 comets, ROI for AChR region was created based on the shape and location of AChR clusters, while ROI for non-AChR region was also created at the adjacent area in the same muscle cell. The number and speed of EB1 comets were measured from multiple frames in 7 s time-lapse images using TrackMate plugin in ImageJ ([@bib41]). The density of EB1 comets was calculated by dividing the number of EB1 comets by the ROI area.

To quantify the FRAP experiments, the relative fluorescence intensity in the photobleached area was first measured and then normalized by the mean fluorescence intensity of the same region in the images acquired before photobleaching. The recovery half-time was determined by the time required for 50% recovery of fluorescence signals in the FRAP regions.

To quantify the number of MT1-MMP-pHluorin surface insertion events, ROI was created at the region of aneural AChR clusters. After photobleaching, the number of MT1-MMP-pHluorin signals in the ROI was measured from multiple frames in 60 s time-lapse images using TrackMate plugin in ImageJ. It was then normalized to the area of aneural AChR clusters.

To quantify the percentage of nerve-muscle contacts with AChR clustering, muscle cells with nerve contact at the bottom surface were first identified in the phase-contrast images, and then the presence of AChR clusters was scored in the fluorescence images.

To quantify the fluorescence intensity of nerve-induced AChR clusters per unit length of nerve-muscle contact, the integrated fluorescence value of AChR signals was first measured, and then it was normalized to the area of nerve-muscle contacts as determined and measured in the phase-contrast images.

To quantify the density of aneural and nerve-induced synaptic AChR clusters in mouse diaphragm muscles, the total number of AChR clusters was first measured from stack images using Imaris software. The number of nerve-induced synaptic AChR clusters was calculated based on the overlapping of signals between AChR clusters and neurofilaments. The number of aneural AChR cluster was then calculated by subtracting the number of nerve-induced synaptic AChR clusters from the total number of AChR clusters. The calculated numbers were then normalized to the length of the main nerve trunk. Endplate band width was defined by the average distance between two farthest AChR clusters in the muscle fibers along the main nerve trunk. The length of nerve branches was quantified by measuring the average axonal length from the main nerve trunk. Approximately 100 measurements were taken in each diaphragm, and the quantification of the endplate band width and length of branches was performed using the whole diaphragm from at least 3 animals in each genotype.

In all figures, mean and SEM values were shown in the graphs, unless otherwise specified. The numbers of biological replications and the statistical tests applied were specified in the figure legends.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Chan et al. have examined the function of actin-enriched podosome-like structures (PLS) and the trafficking of a matrix metalloprotease, MT1-MMP, in regulating AChR organization at the NMJ. Using mostly the *Xenopus* muscle cultures and fluorescence imaging, the authors show that PLS targets MT1-MMP to the membrane surface via the microtubule capturing mechanism involving EB1 and CLASP; subsequently, local ECM remodelling disperses aneural AChR clusters which then act as a source for synaptic AChR clusters. Nerve-muscle co-cultures are also used to explore the effects of interfering with MT1-MMP activity on agrin and nerve-induced AChR cluster formation. Notably, the loss of MT1-MMP activity compromises synaptic AChR cluster formation in vitro and in vivo. Collectively, the findings highlight the crucial role for MT1-MMP in ECM remodeling and AChR re-organization and the underlying cellular and molecular events at the developing NMJ.

**Decision letter after peer review:**

\[Editors' note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.\]

Thank you for submitting your work entitled \"Podosome-directed MT1-MMP trafficking and surface insertion regulate AChR clustering and remodeling at developing NMJs\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Colin Adrain (Reviewer \#3).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*, at least in its present form. If you disagree that the further experiments requested here are valuable/necessary, we expect that you will take this work to another journal at this time. If you agree with the general thrust of the reviewers\' comments and should decide to do further experimental work, we would be open to receiving a new submission with that work, assuming it is responsive to this critique.

The reviewers have acknowledged the importance of the topic and the extensive amount of work involving expert cell biological analyses. However, all three reviewers have pointed out some shortcomings of the study, especially the lack of compelling experimental evidence for the main conclusion that the AChRs dispersed from aneural clusters serve as the source of synaptic AChR clusters at the NMJ. In addition, the majority of experiments rely on overexpression of MT1-MMP-mCherry, and MT1-MMP is not necessarily selectively targeted to perforations within AChR clusters that raises questions about the model. Finally, mouse experiments using MT1-MMP KO animals are elegant, yet they highlight the possible presynaptic role for MT1-MMP that warrants further clarifications. We hope you will find the reviewer comments appended below to be constructive.

*Reviewer \#1:*

Here Chan et al. set out to determine the function of actin-enriched podosome-like structures (PLS) at the NMJ regulating AChR organization. Using mostly the *Xenopus* muscle cultures and fluorescence imaging, the authors perform experiments to conclude that PLS targets MT1-MMP to the membrane surface via the microtubule capturing mechanism involving EB1 and CLASP, which then locally remodels the ECM to disperse aneural AChR clusters. Nerve-muscle cocultures are also used to explore the effects of interfering with MT1-MMP activity on agrin and nerve-induced AChR cluster formation. Collectively, the findings highlight the crucial role for ECM remodeling in AChR organization, and notably, the loss of MT1-MMP activity compromises synaptic AChR cluster formation in vitro and in vivo. Nevertheless, the manuscript is disjointed between characterizations of aneural AChR remodeling and synaptic AChR remodeling in the presence of motoneurons, where most of the effort is spent on the former, and it remains unclear if dispersed aneural AChR serves as a source for synaptic AChRs. Moreover, the logical flow of the proposed events is not necessarily consistent with the data shown, and there are tendencies for over-interpretation of data. Collectively, these issues reduce the overall impact of the present findings.

1\) Results, subsection "Topologically Complex Structures of PLS-Associated Aneural AChR Clusters Can Be Induced by Different ECM Proteins". \"These data suggested that different ECM proteins can induce the assembly of PLSs, which in turn regulates the formation and/or remodeling of topologically complex structures of AChR clusters\": Only the first half of the statement is supported by the data shown.

2\) Figure 2. One should clarify whether block of MMP affects the formation of perforated AChR clusters in any way. Especially with respect to panel G, it is not clear whether the total number of AChR cluster changes over time in control and how this is changed in the presence of MMP inhibitors. In addition to% muscle cells with AChR clusters, one should determine the changes in the number of AChR clusters to demonstrate whether MMP activity is restricted to remodeling of preformed AChR clusters or whether it affects new AChR cluster formation.

3\) Results, subsection "MMP-Mediated ECM Degradation Regulates Topological Remodeling of Aneural AChR Clusters". \"These data demonstrated that MMP activity is required for the topological remodeling and dispersal of aneural AChR clusters\". This statement is not fully substantiated by the data shown as Figure 2I illustrates that some degree of remodeling does seem to occur even in the presence of BB-94 for most of the experiments.

4\) Figure 3A, Figure 4---figure supplement 1 and Figure 5---figure supplement 1. MT1-MMP is not necessarily selectively targeted to perforations within AChR clusters. Also, hotspots of endogenous EB1 are also not necessarily restricted to areas of perforated AChR clusters.

5\) Results, subsection "MT1-MMP Activity Precisely Controls the Extent of ECM Degradation and AChR Cluster Formation". \"\[...\] MT1-MMP-mCherry overexpressing cells showed a higher percentage of top AChR clusters at the expense of ECM-induced bottom AChR clusters \[...\]\". The claim that the increase in the proportion of muscle cells that show top AChR clusters occurred \"at the expense of bottom AChR clusters\" is an overinterpretation of the data. Unless one knows the absolute numbers, one cannot claim for a compensatory effect.

6\) Figure 3D. Despite the fact that MMP inhibitors could prevent the reduction in the intensities of gelatin and AChR induced by overexpression of MT1-MMP-mCherry, the finding that muscle cells knocked-down for endogenous MT1-MMP could still support AChR accumulation of AChR at nerve-muscle contacts albeit inefficiently, which presumably occurs via recruiting of aneural AChR clusters (Figure 7) raises concerns about interpretation of MT1-MMP overexpression experiments.

7\) Figure 4A-C. The analysis of EB1 dynamics at non-AChR regions should target hotspots of EB1 whose intensity matches those associated to AChR-associated regions (cf. Figure 4---figure supplement 1).

8\) Figure 4D and Results, subsection "Cortical Microtubule Capturing Is Mediated by EB1-/CLASP-Dependent Mechanisms at Perforated AChR Clusters". \"\[...\] EB1-GFP signals were primarily enriched at the edge of perforations of aneural AChR clusters in control cells but at the center of perforations in CLASP-MO muscle cells.\" No quantified data is presented in support of the claim. Moreover, because AChR clusters are already found to be perforated in CLASP-MO muscle cells, it is not clear how AChR remodeling is dependent on EB1-/CLASP-mediated targeting of MT1-MMP via PLS.

9\) Results, subsection "Intracellular Trafficking of MT1-MMP Is Directed to PLS-Associated AChR Clusters". \"\[...\] these data illustrated that EB1 coordinates the vesicular trafficking of MT1-MMP in cultured muscle cells\". The observation of spatiotemporally correlated EB1-GFP and MT1-MMP-mCherry signals alone does not compellingly support the claim here. How prevalent are such behaviors?

10\) Results, subsection "Surface Insertion of MT1-MMP Is Correlated with the Formation and Remodeling of AChR Clusters". \"\[...\] we further determined the causal relationship between surface localization of MT1-MMP and topological remodeling of AChR clusters \[\...\]\". The experiments shown here do not establish the causal relationship but rather show whether the two events occur in parallel.

11\) Figure 6. As commented above, experiments involving overexpression of MT1-MMP, especially with respect to AChR remodeling, is difficult to interpret due to possible non-specific effects of exogenous overexpression. Note that overexpressed MT1-MMP localization is not limited to AChR cluster regions.

12\) Results, subsection "Pharmacological Inhibition of MMP Activity Suppresses the Assembly of Synaptic AChR Clusters and the Disassembly of Aneural AChR Clusters". \"In control cells, we detected a gradual dispersal of aneural AChR clusters upon agrin-bead stimulation for 24h; however, those clusters in agrin bead-contacted muscle cells were greatly stabilized by BB-94 or BB-2516 (Figure 7D and Figure 7---figure supplement 1A).\" Contrary to the statement, Figure 7---figure supplement 1A appears to show a lack of difference between control and MMP inhibitors for the decline in the area of aneural AChR clusters.

13\) Figure 7---figure supplement 2B and Results, subsection "Pharmacological Inhibition of MMP Activity Suppresses the Assembly of Synaptic AChR Clusters and the Disassembly of Aneural AChR Clusters". The plot does not seem show a time-dependent increase in aneural AChR clusters in the presence of agrin (4h vs. 8h), which is different from the statement.

*Reviewer \#2:*

In this paper the authors tested the idea podosome-like structure (PLS)-directed MT1-MMP trafficking and surface insertion in modulating the assembly and topological remodeling of AChR clusters via focal matrix degradation at developing neuromuscular synapses. First, by culturing frog myotomal tissues on glass coverslips coated with a mixture of ECM proteins, they showed that aneural AChR clusters were formed at the bottom surface of muscle cells in contact with ECL-coated plates (compared with control -- coated with poly-D-lysine, PDL) while AChR clutters were sparsely scattered. A majority of ECM-induced AChR clusters appeared perforated; and, ECM markers were enriched in the perforations. By plating muscle cells on FITC-gelatin-coated plates, they showed gelatin degradation in the perforation areas of AChR clusters; and MMP inhibitors, BB-94 and BB-2516, inhibited gelatin degradation and increased muscle fibers with AChR clusters and cluster areas, demonstrating that MMP activity is required for podosome formation and AChR cluster stability. Next, the authors showed that MT1-MMP is enriched in the perforated areas and MT1-MMP mCherry overexpression reduced bottom AChR clusters and increased top clusters. By micro-injecting CLASP-MO and using TIRF, they confirmed CLASP involvement in microtubule capturing at AChR clusters; PLS regulates microtubule capturing and MT1-MMP trafficking to AChR clusters. Then, the authors showed that MMP inhibitors inhibit nerve-induction of AChR clusters and disassembly of aneural clusters. In another set of experiments, MT1-MMP was shown to be necessary for surface expression of new AChR and redistribution of pre-existing AChR. Finally, in MT1-MMP null mice, AChR cluster density and endplate band width were reduced, and nerve terminals were defasciculated. These in vivo data seemed in agreement with in vitro data. Together the authors concluded that MT1-MMP regulates the formation and topological remodeling of postsynaptic specializations at developing NMJs.

This is a cell biology-heavy paper with many cutting edge imaging techniques and in vitro manipulations. Data seemed to be solid. Importantly, some conclusions are supported by data of studies of MT1-MMP mutant mice. However, the following concerns should be addressed before publication.

First, podosome is a morphological phenomenon of some cells in culture. Its in vivo implication remains unclear, in particular at the NMJ. It seemed premature to indicate that in the title. It is misleading to state \"podosome-directed MT1-MMP trafficking\". I would like to suggest changing to \"ECM-directed...\".

Second, cell biology data of this paper touched upon a critical issue in NMJ formation -- whether the formation of nerve-induced AChR clusters requires the usage of AChR molecules from aneural clutters. The paper showed a correlation for nerve-induction of new clusters versus and disassembly of aneural clusters, which was not new (showed by Peng and colleagues a while back). This paper could be substantially improved by addressing this question. Such in vitro experiments are not too difficult to do.

Third, along the same line, the authors suggested the coupling forming new, nerve-induced clutters with disappearing aneural clusters. However, the paper stopped short in studying MT1-MMP mutant mice. Adding one or more time point(s) should reveal which step(s) is altered. For in vivo studies, imaging and quantification data should be provided regarding \"aneural\" versus \"nerve-induced\" clusters. Unfortunately such data are missing in the current version.

Fourth, citation of the papers was generous. Recent reviews on NMJ formation were not cited. The author cited a paper on Yap in tumor. There seemed to be one paper on Yap at NMJ.

Fourth, MT-MMPs have six type (MT1-6). Is MT1-MMP a dominant one? No functional redundancy? Figure 3A, MT1-MMP was distributed everywhere, not specific for AChR clusters. Data for the specificity of the antibody. How about in vivo/muscle staining? At the NMJ? Can some podosome-like phenotypes be observed in muscle cells isolated from MT1-MMP mt mice?

Finally, data such as ECM in AChR podosomes and CLASP involvement were published before. Should this be presented in supplement? Rationales for some experiments such as cortical microtubule in MT1-MMP trafficking could have been better described.

*Reviewer \#3:*

This manuscript by Chan and colleagues involves an intricate cell biological dissection of the regulation of acetylcholine receptor (AChR) clustering and remodeling at the neuromuscular junction (NMJ), with a major focus on how this is regulated at the post-synaptic level. This addresses an important topic and in my view, the work is largely well executed and the conclusions robust.

The authors first establish in vitro conditions to characterize the regulation and behavior of AChR clustering under aneural conditions, coming to the conclusion, demonstrated by morpholino and inhibitor studies, that the metalloprotease MT1-MMP (MMP-14) is required for the organization and formation of AChR clusters. The authors further characterize how microtubule capturing mechanisms regulate the dynamics and recruitment of MT1-MMP to the cell surface, as well as the impact on AChR clustering.

Finally, the in vitro/ex vivo analyses are brought together at the end by an examination of the impact of MT1-MMP loss on MNJ formation in mouse embryos. Here the authors conclude that global MT1-MMP embryos have defects in AChR density as well as exhibiting a significant reduced width of end plate bands in developing NMJs. Notably, there are also effects on axonal growth and arborization of the phrenic nerve, making it difficult to conclude, as acknowledged by the authors, that pre-synaptic roles cannot also be ruled out for MT1-MMP.

Overall this is an extensive body of work.

\[Editors' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for submitting your article \"Site-directed MT1-MMP trafficking and surface insertion regulate AChR clustering and remodeling at developing NMJs\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Anna Akhmanova as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Lin Mei (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Here Chan et al. set out to determine the function of actin-enriched podosome-like structures (PLS) and the trafficking of a matrix metalloprotease, MT1-MMP, in regulating AChR organization at the NMJ. Using mostly the *Xenopus* muscle cultures and fluorescence imaging, the authors demonstrate that PLS targets MT1-MMP to the membrane surface via the microtubule capturing mechanism involving EB1 and CLASP; subsequently, local remodelling of the ECM disperses aneural AChR clusters which then act as a source for synaptic AChR clusters. Nerve-muscle co-cultures are also used to explore the effects of interfering with MT1-MMP activity on agrin and nerve-induced AChR cluster formation. Collectively, the findings highlight the crucial role for ECM remodelling in AChR re-organization, and notably, the loss of MT1-MMP activity compromises synaptic AChR cluster formation in vitro and in vivo.

In the revised manuscript, the authors have made significant efforts to address the previous criticisms by performing new experiments and additional analysis. In particular, the study has been significantly strengthened by the FRAP experiment which supports the idea that synaptic AChRs are recruited from aneural AChRs. Furthermore, the text has been carefully edited to improve the clarity of the data interpretations. Altogether, the study makes a compelling case for a role MT1-MMP in NMJ formation. However, following remaining points require careful consideration.

Essential revisions:

Importantly, \"AChR clusters\" in the paper are heterogeneous. Therefore, AChR clusters whose formation is triggered by specific stimuli that are found in different locations, may be under different regulatory mechanisms. For example, ECM-induced clusters are located at the bottom surface of myotubes (i.e. surface in direct contact with the ECM), and these clusters seem to be a target of MT1. Whether the effects of MT1 on these \"bottom\" clusters also apply to AChR clusters on the top surface and/or nerve-induced clusters (which usually are located on the lateral sides of myotubes) remain a critical issue. While it may be beyond the scope of the current study to experimentally clarify the role of MT1 on different AChR cluster types, at the very least, the authors should define these types of AChR clusters in the Introduction. A full discussion of whether and/how MT1 regulates all or just one of the AChR cluster types should be included along with a cartoon.

10.7554/eLife.54379.sa2

Author response

\[Editors' note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors' response to the first round of review.\]

Four major sets of new data are included in this revision in response to reviewers' comments:

1\) Contribution of AChRs from aneural to synaptic clusters. All reviewers raised an important question regarding whether aneural AChR clusters serve as a source for the assembly of synaptic AChR clusters. We agree that our previous manuscript lacks the compelling experimental evidence to show the direct contribution of aneural AChR clusters at developing NMJs. In this revision, we have performed this key experiment using laser-based photobleaching approach to demonstrate the differential contribution of AChR molecules from aneural clusters and diffuse AChRs for the assembly of nerve-induced synaptic AChR clusters. Importantly, we have also investigated the involvement of MT1MMP in this recruitment process. The new data are now presented in Figure 9.

2\) Aneural versus synaptic AChR clusters in MT1-MMP^-/-^ knockout study. We agree with reviewer \#2 that our manuscript could be further strengthened by providing additional imaging and quantification data to show both aneural and synaptic AChR clusters at developing NMJs in vivo. As such, we have now performed new quantitative analyses on our existing and new imaging data to measure the numbers of aneural and synaptic AChR clusters between wild-type and MT1-MMP knockout animals. The new in vivo analyses are now presented in Figure 10C-G.

3\) Possible presynaptic role of MT1-MMP at NMJs in vivo. We appreciate the comments from reviewer \#3 indicating that it is outside the scope of our present manuscript to determine whether MT1-MMP plays a presynaptic role at developing NMJs in vivo. As suggested by the reviewer, we have now performed the immunostaining experiment using rat leg muscles. Our new results indicated that denervation caused only a slight reduction of MT1-MMP signals at the NMJs, suggesting MT1-MMP is expressed in postsynaptic muscles primarily, but also in presynaptic motor neurons at a lower level. The new in vivo data are now presented in Figure 10B.

4\) Spatial localization of endogenous and overexpressed MT1-MMP in AChRclusters. Reviewers \#1 and \#2 raised concerns about the spatial localization of endogenous and overexpressed MT1-MMP, as their signals are not selectively restricted to the perforations of aneural AChR clusters. In the revised manuscript, we have now provided additional data using MT1-MMP antibody that was pre-incubated with recombinant MT1-MMP proteins to demonstrate the specificity of MT1-MMP signals at NMJs in vivo in Figure 10A. Moreover, we have further clarified that signals of MT1-MMP immunostaining and MT1-MMP-mCherry overexpression are derived from both surface and intracellular MT1-MMP proteins, explaining why it is reasonable that endogenous and overexpressed MT1-MMP signals are not restricted to AChR clusters.

> Reviewer \#1:
>
> \[...\] The manuscript is disjointed between characterizations of aneural AChR remodeling and synaptic AChR remodeling in the presence of motoneurons, where most of the effort is spent on the former, and it remains unclear if dispersed aneural AChR serves as a source for synaptic AChRs.

We thank the reviewer for the comment. In this revision, we have further provided a direct evidence demonstrating the contribution of AChRs from the aneural to synaptic clusters at developing NMJs in Figure 9. Our new results showed that a majority of AChRs at the nerve-muscle contacts are recruited from aneural AChR clusters, and this recruitment process is significantly reduced in MT1-MMP knockdown muscle cells.

> Moreover, the logical flow of the proposed events is not necessarily consistent with the data shown, and there are tendencies for over-interpretation of data. Collectively, these issues reduce the overall impact of the present findings.

We have now modified the schematic diagram (Figure 11B) by including the relevant data presented in our main figures that support each of the individual proposed events in this logical flow diagram. Moreover, we have toned down several overstatements throughout the revised manuscript. With these changes, we hope that the reviewer and the general audience would better appreciate the overall impact of this study.

> 1\) Results, subsection "Topologically Complex Structures of PLS-Associated Aneural AChR Clusters Can Be Induced by Different ECM Proteins". \"These data suggested that different ECM proteins can induce the assembly of PLSs, which in turn regulates the formation and/or remodeling of topologically complex structures of AChR clusters\": Only the first half of the statement is supported by the data shown.

We apologize for the over-interpretation in this sentence. In this study, we have demonstrated that the formation of bottom AChR clusters could be effectively induced by all ECM proteins tested (Figure 1B), and we have identified PLS localization in a majority of perforated AChR clusters induced by different ECM proteins (Figure 1D-E). Therefore, we have revised the sentence - "These data suggest that different ECM proteins can induce the assembly of PLSs, which may in turn regulate the formation of topologically complex structures of AChR clusters".

> 2\) Figure 2. One should clarify whether block of MMP affects the formation of perforated AChR clusters in any way. Especially with respect to panel G, it is not clear whether the total number of AChR cluster changes over time in control and how this is changed in the presence of MMP inhibitors. In addition to % muscle cells with AChR clusters, one should determine the changes in the number of AChR clusters to demonstrate whether MMP activity is restricted to remodeling of preformed AChR clusters or whether it affects new AChR cluster formation.

We agree with the reviewer that our original Figure 2G did not clearly show the total number of AChR clusters changes over time in control and in the presence of MMP inhibitors. In this revision, we have modified the presentation of the data in the original Figure 2G. Two separate panels are now added to show the effects of MMP inhibition on the formation (Figure 2G) and remodeling (Figure 2H) of AChR clusters. Moreover, we have included the new quantitative data as [Author response image 1](#respfig1){ref-type="fig"}, showing that there is no significant difference in the total number of AChR clusters between control and MMP inhibitor-treated muscle cells. These data indicated that MMP inhibition affects the remodeling of preformed AChR clusters, rather than the formation of new AChR clusters.

![Quantitative analysis on the total AChR clusters in cultured cells treated with MMP inhibitors.\
By monitoring muscle cells over 4 days in culture, AChR clusters located in the top versus bottom surface of the muscle cells were quantified in different experimental groups. Data are represented as mean ± SEM. n = 150 muscle cells in each experimental group from 3 independent experiments.](elife-54379-resp-fig1){#respfig1}

> 3\) Results, subsection "MMP-Mediated ECM Degradation Regulates Topological Remodeling of Aneural AChR Clusters". \"These data demonstrated that MMP activity is required for the topological remodeling and dispersal of aneural AChR clusters\". This statement is not fully substantiated by the data shown as Figure 2I illustrates that some degree of remodeling does seem to occur even in the presence of BB-94 for most of the experiments.

It is true that a small degree of remodeling of aneural AChR clusters can be detected in the presence of MMP inhibitors. This is due to the fact that the activity of MMPs cannot be completely blocked by pharmacological inhibitors. However, it should be noted that we observed a significant inhibition of AChR cluster remodeling in response to BB-94 treatment (Figure 2I-J). Therefore, we have toned down the quoted sentence -- "These data demonstrated that MMP activity is involved in the topological remodeling and dispersal of aneural AChR clusters".

> 4\) Figure 3A, Figure 4---figure supplement 1 and Figure 5---figure supplement 1. MT1-MMP is not necessarily selectively targeted to perforations within AChR clusters. Also, hotspots of endogenous EB1 are also not necessarily restricted to areas of perforated AChR clusters.

We thank the reviewer for this comment. We would like to emphasize that MT1-MMP immunostaining data in Figure 3A and Figure 5---figure supplement 1 indicated the signals from not only surface MT1-MMP, but also intracellular MT1-MMP at the vesicular compartments. Therefore, it was expected that MT1-MMP signals in Figure 3A are not selectively restricted to the perforations of aneural AChR clusters. We have emphasized this in the third paragraph of the Discussion.

Regarding the endogenous EB1 signals, we also expected that EB1 signals are not selectively restricted to perforated AChR clusters. As EB1 is a microtubule plus-end-binding protein responsible for regulating microtubule dynamics, endogenous EB1 comets could be found throughout the entire cell. In addition to the location of aneural AChR clusters, it is known that focal adhesions at the cell periphery can also regulate cortical microtubule capturing, representing another possible site of EB1 hotspots in muscle cells. We have now clarified this in the fourth paragraph of the Discussion.

> 5\) Results, subsection "MT1-MMP Activity Precisely Controls the Extent of ECM Degradation and AChR Cluster Formation". \"\[...\] MT1-MMP-mCherry overexpressing cells showed a higher percentage of top AChR clusters at the expense of ECM-induced bottom AChR clusters \[...\]\". The claim that the increase in the proportion of muscle cells that show top AChR clusters occurred \"at the expense of bottom AChR clusters\" is an overinterpretation of the data. Unless one knows the absolute numbers, one cannot claim for a compensatory effect.

We agree with the reviewer on this. This statement has been toned down -- "MT1-MMP-mCherry overexpressing cells showed a lower percentage of ECM-induced bottom AChR clusters, but a higher percentage of top AChR clusters, in comparison to the wild-type control cells".

> 6\) Figure 3D. Despite the fact that MMP inhibitors could prevent the reduction in the intensities of gelatin and AChR induced by overexpression of MT1-MMP-mCherry, the finding that muscle cells knocked-down for endogenous MT1-MMP could still support AChR accumulation of AChR at nerve-muscle contacts albeit inefficiently, which presumably occurs via recruiting of aneural AChR clusters (Figure 7) raises concerns about interpretation of MT1-MMP overexpression experiments.

We thank the reviewer for pointing this out. We would like to clarify that MT1-MMP serves different roles in regulating the aneural (Figure 3) and synaptic (Figures 7-8) AChR clusters. As the reviewer pointed out, nerve-muscle contacts in the chimeric co-cultures of MT1-MMP-MO muscles and wild-type neurons could still allow the accumulation of some AChRs, albeit inefficiently. This could be explained by: (1) the partial knockdown of endogenous muscle MT1-MMP level by MT1-MMP MO (Figure 8---figure supplement 1); (ii) the recruitment of diffuse AChRs to nerve-muscle contacts, although it is a minor contribution, via MT1-MMP-independent processes (Figure 9). Therefore, it is not contradictory with the findings of MT1-MMP overexpression in aneural AChR cluster formation (Figure 3). We have now clarified this in the subsection "Postsynaptic MT1-MMP is a regulator of NMJ development".

> 7\) Figure 4A-C. The analysis of EB1 dynamics at non-AChR regions should target hotspots of EB1 whose intensity matches those associated to AChR-associated regions (cf. Figure 4---figure supplement 1).

Apart from the region of aneural AChR clusters, focal adhesion structures located at the cell periphery are the other site of EB1 hotspots in the muscle cells. Therefore, we performed the suggested analysis to compare EB1-GFP dynamics between AChR and focal adhesion regions. As shown in [Author response image 2](#respfig2){ref-type="fig"}, the speed of EB1 comets was comparable between AChR and focal adhesion regions. However, CLASP knockdown significantly increased the speed of EB1 comets in AChR regions but not in focal adhesion regions. These data suggested that while cortical microtubule capturing is detected at both aneural AChR clusters and focal adhesion structures, the former is more sensitive to CLASP expression level.

![Cortical microtubule capturing at AChR and focal adhesion regions.\
(**A**) Representative TIRF images showing the hotspots of EB1-GFP comets in AChR clusters and focal adhesion (FA) structures in control or CLASP-MO muscle cells. (**B**) Quantitative analyses showing the speed of EB1-GFP comets in AChR cluster and focal adhesion regions between control and CLASP-MO muscle cells. n = 15 (Control) and 13 (CLASP-MO) cells from 4 independent experiments. Scale bar represents 10 μm. Data are represented as mean ± SEM. Student's t-test, \* represents p ≤ 0.05.](elife-54379-resp-fig2){#respfig2}

> 8\) Figure 4D and Results, subsection "Cortical Microtubule Capturing Is Mediated by EB1-/CLASP-Dependent Mechanisms at Perforated AChR Clusters". \"\[...\] EB1-GFP signals were primarily enriched at the edge of perforations of aneural AChR clusters in control cells but at the center of perforations in CLASP-MO muscle cells.\" No quantified data is presented in support of the claim.

To better show the spatial patterns of EB1-GFP signals at the perforations of aneural AChR clusters in control versus CLASP-MO muscle cells, we have now plotted the fluorescence intensity profiles of EB1-GFP and AChR across a perforated region of AChR clusters. Our new analysis clearly indicated the enrichment of EB1-GFP at the edge of perforations in control cells, but at relatively closer to the centre of perforations in CLASP-MO muscle cells. The new data are now presented in Figure 4E.

However, different perforations in different, and even the same, aneural AChR clusters exhibit a great diversity and variations in terms of their size, shape, and intensity difference. This prevented us from performing other quantitative analyses to further support our claim.

> Moreover, because AChR clusters are already found to be perforated in CLASP-MO muscle cells, it is not clear how AChR remodeling is dependent on EB1-/CLASP-mediated targeting of MT1-MMP via PLS.

Western blotting analysis in Figure 4---figure supplement 2 showed that CLASP protein level is largely reduced, but not completed abolished, in the condition of morpholino-mediated CLASP knockdown. The residual CLASP protein level explained why perforated AChR clusters were able to form in CLASP-MO muscle cells. Since CLASP can control other cellular events (e.g. to maintain a stable spindle position in mitosis (Samora et al., 2011)), it is not desirable to further increase the knockdown efficiency of endogenous CLASP in our experiments.

> 9\) Results, subsection "Intracellular Trafficking of MT1-MMP Is Directed to PLS-Associated AChR Clusters". \"\[...\] these data illustrated that EB1 coordinates the vesicular trafficking of MT1-MMP in cultured muscle cells\". The observation of spatiotemporally correlated EB1-GFP and MT1-MMP-mCherry signals alone does not compellingly support the claim here. How prevalent are such behaviors?

As stated in our response to comment \#4 above, EB1 is a microtubule plus-end binding protein responsible for regulating microtubule dynamics. The intracellular trafficking of MT1-MMP vesicles can be mediated throughout the entire microtubule networks. Even though we were able to observe cases when EB1 comets search and capture MT1-MMP vesicles (Figure 5A), the exact location of MT1-MMP vesicles is not selectively restricted at/near the plus-end of microtubules. Therefore, it is not feasible to perform quantitative analysis on the prevalence of such behaviors.

> 10\) Results, subsection "Surface Insertion of MT1-MMP Is Correlated with the Formation and Remodeling of AChR Clusters". \"\[...\] we further determined the causal relationship between surface localization of MT1-MMP and topological remodeling of AChR clusters \[\...\]\". The experiments shown here do not establish the causal relationship but rather show whether the two events occur in parallel.

We apologize for this overstatement. The quoted sentence has been toned down -- "\[...\] we further determined the correlation between surface localization of MT1-MMP and topological remodeling of AChR clusters \[...\]".

> 11\) Figure 6. As commented above, experiments involving overexpression of MT1-MMP, especially with respect to AChR remodeling, is difficult to interpret due to possible non-specific effects of exogenous overexpression. Note that overexpressed MT1-MMP localization is not limited to AChR cluster regions.

We understand the concern about the possible non-specific effects of MT1-MMP overexpression for the study of AChR cluster remodeling. In contrast to MT1-MMP-mCherry overexpression that showed both surface and intracellular MT1-MMP signals (Figure 5), the localization of MT1-MMP-pHluorin signals at a low expression level was indeed more restricted to AChR cluster regions (Figure 6A). Therefore, to minimize the non-specific effects of exogenous overexpression, only those cells with low MT1-MMP-pHluorin expression levels were chosen for the study of AChR cluster remodeling (Figure 6D-H). Taking all these into account, MT1-MMP-pHluorin is still considered as a very useful tool to demonstrate the surface insertion of MT1-MMP in our experiments. We have now further emphasized this point in the Discussion section.

> 12\) Results, subsection "Pharmacological Inhibition of MMP Activity Suppresses the Assembly of Synaptic AChR Clusters and the Disassembly of Aneural AChR Clusters". \"In control cells, we detected a gradual dispersal of aneural AChR clusters upon agrin-bead stimulation for 24h; however, those clusters in agrin bead-contacted muscle cells were greatly stabilized by BB-94 or BB-2516 (Figure 7D and Figure 7---figure supplement 1A).\" Contrary to the statement, Figure 7---figure supplement 1A appears to show a lack of difference between control and MMP inhibitors for the decline in the area of aneural AChR clusters.

We realize that plotting the three experimental groups as a mixed population in the original figure was difficult for data interpretation. We have now presented the data points in each experimental groups side by side in Figure 7---figure supplement 1A. Additionally, statistical analyses have been performed to show that BB-94 and BB-2516 significantly suppressed the decline in the area of aneural AChR clusters upon agrin bead stimulation, compared with the control group.

> 13\) Figure 7---figure supplement 2B and Results, subsection "Pharmacological Inhibition of MMP Activity Suppresses the Assembly of Synaptic AChR Clusters and the Disassembly of Aneural AChR Clusters". The plot does not seem show a time-dependent increase in aneural AChR clusters in the presence of agrin (4h vs. 8h), which is different from the statement.

We have now clarified this confusing statement in the revised manuscript -- "\[...\] we performed immunostaining experiments, in which we demonstrated an increase of endogenous MT1-MMP signals at aneural AChR clusters upon agrin stimulation (Figure 7---figure supplement 2)".

> Reviewer \#2:
>
> \[...\] This is a cell biology-heavy paper with many cutting edge imaging techniques and in vitro manipulations. Data seemed to be solid. Importantly, some conclusions are supported by data of studies of MT1-MMP mutant mice. However, the following concerns should be addressed before publication.
>
> First, podosome is a morphological phenomenon of some cells in culture. Its in vivo implication remains unclear, in particular at the NMJ. It seemed premature to indicate that in the title. It is misleading to state \"podosome-directed MT1-MMP trafficking\". I would like to suggest changing to \"ECM-directed...\".

We agree with the reviewer that it is premature to use "podosome-directed MT1-MMP trafficking" in the title. While we have considered the suggestion of using "ECM-directed MT1-MMP trafficking", our data demonstrated that MT1-MMP is indeed targeted to and inserted at the perforated regions of AChR clusters, where extensive degradation of ECM proteins is spatially detected. Therefore, using "ECM-directed MT-MMP trafficking..." does not truly reflect our main findings in this study. In this revised manuscript, we have decided to revise the title as, "Site-directed MT1-MMP trafficking and surface insertion regulate AChR clustering and remodeling at developing NMJs".

> Second, cell biology data of this paper touched upon a critical issue in NMJ formation -- whether the formation of nerve-induced AChR clusters requires the usage of AChR molecules from aneural clutters. The paper showed a correlation for nerve-induction of new clusters versus and disassembly of aneural clusters, which was not new (showed by Peng and colleagues a while back). This paper could be substantially improved by addressing this question. Such in vitro experiments are not too difficult to do.

We thank the reviewer for this excellent suggestion. In this revision, we have performed this key experiment using photobleaching approach to demonstrate the differential contribution of AChR molecules from aneural clusters and diffuse AChRs for the assembly of nerve-induced synaptic AChR clusters. The new data are now presented in Figure 9.

> Third, along the same line, the authors suggested the coupling forming new, nerve-induced clutters with disappearing aneural clusters. However, the paper stopped short in studying MT1-MMP mutant mice. Adding one or more time point(s) should reveal which step(s) is altered. For in vivo studies, imaging and quantification data should be provided regarding \"aneural\" versus \"nerve-induced\" clusters. Unfortunately such data are missing in the current version.

We agree with the reviewer that imaging and quantifying aneural versus synaptic AChR clusters at different embryonic stages would be of help to further support the coupling events between aneural AChR cluster dispersal and synaptic AChR cluster formation at developing NMJs. Thus, we have now classified all AChR signals into aneural and synaptic AChR clusters in wild-type and MT1-MMP^-/-^ diaphragm muscles at E13.5 and E18.5, which are now presented in Figure 10C-E. At E13.5, we observed a significant increase in the density of aneural AChR clusters in MT1-MMP^-/-^ compared with that in the wild-type animals (Figure 10D). In contrast, the density of synaptic AChR clusters in MT1-MMP^-/-^ was significantly lower than that in wild-type animals at E18.5 (Figure 10E). This new quantitative data further supported that MT1-MMP is involved in the recruitment of aneural AChR clusters to nerve-induced synaptic AChR clusters at developing NMJs in vivo.

In addition, we have tried to add an additional time point (E15.5) for examining the AChR clusters in embryonic diaphragm muscles between wild-type and MT1-MMP-deficient mice. Unfortunately, because of the low breeding performance of our existing MT1-MMP^-/-^ colonies, we were able to obtain only one homozygous MT1-MMP knockout embryo in the past 6 months. From our preliminary data as shown in [Author response image 3](#respfig3){ref-type="fig"}, the effects on the density of aneural versus synaptic AChR clusters between the wild-type and MT1-MMP^-/-^ mice at E15.5 showed a similar trend as what we observed using E13.5 mice (Figure 10D-E). With the new analysis suggested by the reviewer as stated above, we think that the comparison between E13.5 and E18.5 is sufficient to demonstrate the coupling events between the dispersal of aneural AChR clusters and the formation of synaptic AChR clusters.

Nevertheless, if the reviewers consider this as an essential experiment for the revision, we are in the process of replacing the poor breeders, and therefore we shall be able to obtain more homozygous MT1-MMP knockout mice for this study in the next couple of months.

![Aneural versus synaptic AChR clusters in MT1-MMP^-/-^ diaphragm muscles at E15.5.\
(**A**) Representative confocal images showing the AChR pre-patterns (red) and synaptic AChR clusters (yellow) in whole-mount diaphragms from control and MT1-MMP^-/-^ mice at E15.5. Whole-mount tissues were stained for AChR and neurofilament (NF). (B-E) Quantification on the density of aneural (**B**) versus synaptic (**C**) AChR clusters, the width of end-plate bands (**D**), and the length of axonal branches (**E**) in diaphragm muscles between wild-type and MT1-MMP^-/-^ mouse embryos. n = 3 (WT) and 1 (MT1-MMP^-/-^) embryos from 1 experiment only. Data are represented as mean ± SEM (WT). Scale bar represents 50 μm.](elife-54379-resp-fig3){#respfig3}

> Fourth, citation of the papers was generous. Recent reviews on NMJ formation were not cited. The author cited a paper on Yap in tumor. There seemed to be one paper on Yap at NMJ.

We apologize for missing out some important, recently published review and research papers on NMJ formation. We have now included several recent reviews on NMJ development (Li et al., 2018; Wu et al., 2010), and the research article on Yap at NMJ (Zhao et al., 2017) in the revised manuscript.

> Fifth, MT-MMPs have six type (MT1-6). Is MT1-MMP a dominant one? No functional redundancy? Figure 3A, MT1-MMP was distributed everywhere, not specific for AChR clusters. Data for the specificity of the antibody. How about in vivo/muscle staining? At the NMJ?

Among the six membrane-type MMPs, MT1-MMP has been widely studied since its identification and is involved in ECM remodeling in physiological and pathological processes. In the present study, morpholino-mediated knockdown of MT1-MMP alone was able to significantly inhibit the formation and dispersal of synaptic and aneural AChR clusters, respectively. Besides, MT1-MMP knockout mice develop multiple abnormalities and die between 50-90 postnatal days (Holmbeck et al., 1999), suggesting that the possibility of functional redundancy by other MMP isoforms is low. We have now further clarified this point in the sixth paragraph of the Discussion.

Regarding the specificity of MT1-MMP antibodies, we have now provided additional data using MT1-MMP antibody that was pre-incubated with recombinant MT1-MMP protein to demonstrate the specificity of MT1-MMP signals at NMJs in vivo in Figure 10A.

> Can some podosome-like phenotypes be observed in muscle cells isolated from MT1-MMP mt mice?

We have now performed immunostaining experiments to examine the localization of ADF/cofilin and talin, core and cortex markers of podosome-like structures respectively, at AChR clusters in hindlimb muscles of wild-type and MT1-MMP^-/-^ postnatal mice. Consistent with a previous study using adenovirus-expressing actin-GFP in tibialis anterior muscles in postnatal day 8 mice (Proszynski et al., 2009), the spatial localization of synaptic podosomes at the NMJs in vivo is not as obvious as that in cultured muscles. Nevertheless, we were able to detect elevated signals of ADF/cofilin and talin associated with synaptic AChR clusters in hindlimb muscles from both wild-type and MT1-MMP^-/-^ mice at postnatal day 11. This indicated that MT1-MMP deficiency causes no or minimal change in the presence of podosome-like structures at NMJs during early postnatal development.

![Localization of PLS core and cortex markers at AChR clusters in postnatal mice.\
Representative confocal images showing the enrichment of PLS core marker, ADF/cofilin (top panels), and cortex marker, talin (bottom panels), at synaptic AChR clusters in longitudinal cryosections of hindlimb muscles isolated from P11 wild-type or MT1-MMP^-/-^ mice. Maximum projection intensity images of 12 z-stack confocal frames with 0.48 µm intervals were constructed using ZEN 2.3 (Carl Zeiss). Scale bar represents 10 μm.](elife-54379-resp-fig4){#respfig4}

> Finally, data such as ECM in AChR podosomes and CLASP involvement were published before. Presented in supplement? Rationales for some experiments such as cortical microtubule in MT1-MMP trafficking could have been better described.

While we acknowledge the previously published works on the involvement of ECM in podosome assembly at AChR clusters and CLASP involvement in this field, we believe that our new data presented in this study provided some novel insights into these processes.

Firstly, our data showed that perforated AChR clusters can be effectively induced by gelatin (Figure 1B and C), an ECM protein that was previously shown to induce simple AChR plaques only (Kummer et al., 2004). Secondly, our TIRF-FRAP experiments demonstrated that EB1-GFP signals were primarily enriched at the edge of perforations of aneural AChR clusters in control cells, but at the center of perforations in CLASP-MO muscle cells (Figure 4D-E). As such, we would prefer to keep these data in the main figure.

We have now further elaborated the rationales of experiments investigating cortical microtubules in MT1-MMP trafficking as suggested -- "As microtubules serve as major tracks for vesicular trafficking in mammalian cells, the cortical microtubule organization plays a crucial role in the targeted delivery of secretory and membrane proteins via exocytosis".

\[Editors' note: what follows is the authors' response to the second round of review.\]

> Essential revisions:
>
> Importantly, \"AChR clusters\" in the paper are heterogeneous. Therefore, AChR clusters whose formation is triggered by specific stimuli that are found in different locations, may be under different regulatory mechanisms. For example, ECM-induced clusters are located at the bottom surface of myotubes (i.e. surface in direct contact with the ECM), and these clusters seem to be a target of MT1. Whether the effects of MT1 on these \"bottom\" clusters also apply to AChR clusters on the top surface and/or nerve-induced clusters (which usually are located on the lateral sides of myotubes) remain a critical issue. While it may be beyond the scope of the current study to experimentally clarify the role of MT1 on different AChR cluster types, at the very least, the authors should define these types of AChR clusters in the Introduction. A full discussion of whether and/how MT1 regulates all or just one of the AChR cluster types should be included along with a cartoon.

We thank the Reviewing Editor and reviewers for raising this crucial point and providing an opportunity for us to clarify this. In most of our experiments, aneural AChR clusters located at the basal muscle surface in direct contact with ECM proteins (i.e. bottom AChR clusters), as well as synaptic AChR clusters located at either the basal surface or the lateral side of muscle cells, were investigated. The central idea of this study is to test whether ECM degradation mediated by MT1-MMP regulates AChR cluster formation and remodeling.

Although it is true that a minority of aneural AChR clusters can be found at the top muscle surface, where no ECM proteins are directly involved, we consider that top AChR clusters are spontaneously formed with no physiological relevance. Thus, we did not investigate the role of MT1-MMP in the formation and remodeling of ECM-independent, top AChR clusters.

As for nerve-induced AChR clusters, most nerve contacts in *Xenopus* primary cultures are located at either the basal surface or the lateral side of muscle cells, in agreement with previous studies (Anderson and Cohen, 1977; Cohen et al., 1987). Since it is uncommon to find nerve contacts at the top surface of cultured muscle cells, they were not included in our study.

We have now added several sentences in different parts of our revised manuscript to further clarify these points:

Introduction:

1\) "These aneural AChR clusters, located at the bottom surface of cultured muscles in direct contact with ECM proteins, ...".

2\) "It is worth to note that a small proportion of aneural AChR clusters can also be identified at the top surface of cultured muscles, and these spontaneously formed clusters are likely mediated through ECM- and PLS-independent mechanisms".

Discussion:

1\) "In agreement with previous studies (Anderson and Cohen, 1977; Cohen et al., 1987), most nerve contacts in *Xenopus* primary cultures are located at either the basal surface or the lateral side of muscle cells, which are influenced by MMP-mediated proteolytic degradation of ECM proteins".

2\) "In a minority of cases, some aneural and nerve-induced AChR clusters can be found at the top muscle surface, where no ECM proteins are directly involved. Particularly, those top aneural AChR clusters are spontaneously formed with possibly no physiological relevance, whether MT1-MMP regulates the formation and remodeling of ECM-independent top AChR clusters remains unknown".

Schematic cartoon:

1\) The schematic diagram has been significantly revised to indicate the role of MT1-MMP in the recruitment of AChRs from bottom aneural clusters to bottom synaptic clusters via focal ECM degradation. This diagram is now presented in Figure 11A, as this does not belong to the supplement of a particular figure.
